















Tânia Keiko Shishido Joutsen 
 
 
Division of Microbiology and Biotechnology 
Department of Food and Environmental Sciences 
Faculty of Agriculture and Forestry 




Integrative Life Science Doctoral Program 















To be presented, with permission of the Faculty of Agriculture and Forestry of the 
University of Helsinki, for public examination in auditorium B2 (A109), at Viikki B-
Building, Latokartanonkaari 7, on May 22
nd





Supervisors  Professor Kaarina Sivonen 
   Department of Food and Environmental Sciences 
   University of Helsinki, Finland 
 
   Docent David P. Fewer 
   Department of Food and Environmental Sciences 
   University of Helsinki, Finland 
 
   Docent Jouni Jokela 
   Department of Food and Environmental Sciences 
   University of Helsinki, Finland 
 
 
Reviewers  Professor Elke Dittmann 
   Institute of Biochemistry and Biology 
   University of Potsdam, Germany 
 
   Professor Pia Vuorela 
   Pharmaceutical Biology, Faculty of Pharmacy 
   University of Helsinki, Finland 
  
 
Thesis committee Professor Mirja Salkinoja-Salonen 
   Department of Food and Environmental Sciences 
   University of Helsinki, Finland 
 
Docent Päivi Tammela 
Centre for drug research, Faculty of Pharmacy 
   University of Helsinki, Finland 
 
 
Opponent  Professor Vitor Vasconcelos 
   Interdisciplinary Centre of Marine and Environmental Research 
   University of Porto, Portugal 
 
 
Custos   Professor Kaarina Sivonen 
   Department of Food and Environmental Sciences 
   University of Helsinki, Finland 
 
 
Cover layout by Anita Tienhaara and Cover image: Mare Balticum, Anabaena sp. 
XSPORK2A and chemical structures of microcystin, anabaenolysin, hassallidin, 
cyclodextrin, scytophycin (from SciFinder and courtesy by Jouni Jokela). 
 
ISSN 2342-3161 (Print) and ISSN 2342-317X (Online) 





Table of Contents 
 
List of publications and author’s contribution  ................................................................................. 4 
Abbreviations  ................................................................................................................................... 5 
Abstract ............................................................................................................................................. 6 
Resumo  ............................................................................................................................................. 7 
Tiivistelmä  ........................................................................................................................................ 8 
 
1. Introduction  ............................................................................................................................... 9 
Cyanobacteria ............................................................................................................................... 9 
Natural products biosynthesis ...................................................................................................... 9 
 Genetic diversity of cyanobacterial nonribosomal peptide and polyketide gene clusters .......... 11 
Evolution of the genes involved in the synthesis of nonribosomal peptides and polyketides ... 17 
Activity of cyanobacterial nonribosomal peptides and polyketides  .......................................... 18 
Drug discovery and development process  ................................................................................. 32 
2. Study aims  ................................................................................................................................ 34 
3. Summary of material and methods  ....................................................................................... 35 
4. Summary of results and discussion ........................................................................................ 36 
Anabaenolysin, hassallidin and microcystin gene clusters (I, II, III) ......................................... 36 
Gene evolution involved in microcystin and anabaenolysin synthesis (I, III)  .......................... 39 
Diversity of cyanobacterial strains producing the studied natural products (I, II, III, IV)  ........ 41 
Activity of the cyanobacterial natural products analyzed in this study (II, III, IV)  .................. 43 
5. Final remarks and future considerations ............................................................................... 45 
6. Acknowledgements ................................................................................................................... 47 
7. References ................................................................................................................................. 48 
 













List of publications 
 
This thesis is based on the following publications and manuscripts: 
 
I  Shishido TK, Kaasalainen U, Fewer DP, Rouhiainen L, Jokela J, Wahlsten M, 
Fiore MF, Yunes JS, Rikkinen J, Sivonen K. 2013. Convergent evolution of [D-
Leucine
1
] microcystin-LR in taxonomically disparate cyanobacteria. BMC 
Evolutionary Biology. 13:86.  
 
II  Vestola J, Shishido TK, Jokela J, Fewer DP, Aitio O, Permi P, Wahlsten M, Wang 
H, Rouhiainen L, Sivonen K. 2014. Hassallidins, antifungal glycolipopeptides, are 
widespread among cyanobacteria and are the end-product of a nonribosomal 
pathway. Proceedings of the National Academy of Science U S A. 111(18):E1909-
17. 
 
III Shishido TK, Jokela J, Kumer C-T, Fewer DP, Wahlsten M, Wang H, Rouhiainen 
L, Rizzi E, Debellis G, Permi P, Sivonen K. Biosynthesis of a unique antifungal 
synergy between the anabaenolysin lipopeptides and cyclodextrins from Anabaena 
(Cyanobacteria). Submitted manuscript. 
 
IV Shishido TK, Humisto A, Jokela J, Liu L, Wahlsten M, Tamrakar A, Fewer DP, 
Permi P, Andreote APD, Fiore MF, Sivonen K. Antifungal compounds from 





The author’s contribution 
 
I Tânia Keiko Shishido Joutsen designed the study, executed most of the 
experimental work, analysis and data interpretation, and wrote the article.  
 
II Tânia Keiko Shishido Joutsen participated in the design of the study, carried out 
part of the research, analysis and data interpretation, and collaborated with the 
other authors in writing the article. 
 
III Tânia Keiko Shishido Joutsen designed the study, carried out the research and data 
analysis, and wrote the article. 
 
IV Tânia Keiko Shishido Joutsen designed the study, carried out the research and data 













A  Adenylation domain 
Aa  Amino acid  
abl  Anabaenolysin gene cluster 
Acc  Acyl-CoA carboxylase 
AccB   Biotin carboxyl carrier protein 
ACP  Acyl carrier protein domain 
AT  Acyl-transferase domain 
bp  Base pairs 
C  Condensation domain 
CoA  Coenzyme A 
DH  Dehydratase domain 
E  Epimerization domain 
EMA  European Medicines Agency  
ER  Enoyl reductase domain 
FAALs  Fatty acyl-AMP ligases 
FACLs Acyl-CoA-synthesizing fatty acyl-CoA ligases 
FADS   Fatty acid desaturase 
FDA  Food and Drug Administration  
has   Hassallidin gene cluster 
HMM  Hidden Markov model 
IC50  Half maximum inhibitory concentration or Concentration at 50% inhibition 
kb  Kilo base pairs 
KR  Ketoreductase domain 
KS  Ketosynthase domain 
Leu or L Leucine 
Mb  Mega base pairs 
mcy   Microcystin gene cluster  
McyA   Protein encoded by the gene mcyA 
McyB  Protein encoded by the gene mcyB 
McyC  Protein encoded by the gene mcyC 
Met  Methionine 
MIC  Minimum inhibitory concentration 
MT  Methyltransferase domain 
NCBI  National Center for Biotechnology Information  
NRPS   Nonribosomal peptides synthetases 
OX   Monooxygenase domain 
PCP  Peptidyl carrier protein domain 
PKS   Polyketide synthases 
Q  Glutamine 
R  Arginine 
T  Threonine 
TE  Thioesterase domain 
WHO   World Health Organization 
X  Unknown amino acid 







Cyanobacteria have a long evolutionary history, dating back to 3500 million years 
ago. They are an ancient lineage of photosynthetic bacteria that contribute to global 
nitrogen and carbon cycles. Cyanobacteria can be found in diverse environments, from 
aquatic to terrestrial systems, with specimens detected and isolated from geothermal, 
hypersaline, polar and desert regions. Cyanobacteria are infamous for the production of 
toxins such as microcystin, cylindrospermopsin, saxitoxin and anatoxin-a. However, many 
different types of cyanobacterial compounds with e.g. antibacterial, antifungal, anticancer, 
antiviral and antiprotozoal activity have also been found. This study aimed at investigating 
the evolution, biosynthesis, chemical variety and antifungal activity of cyanobacterial 
compounds.  
 The results indicate that distantly related cyanobacteria converged on the ability to 
produce a rare variant of microcystin. Microcystins are commonly produced by 
cyanobacteria during blooms, but have recently also been found in benthic and lichen-
associated cyanobacteria. A benthic, a lichen-associated cyanobacterium and two 
planktonic strains were shown to produce [D-Leu
1
] microcystin-LR. Bioinformatic 
analyses indicated that different evolutionary events, i.e. point mutations and gene 
conversion, were involved in this convergent evolution. 
 Over 400 cyanobacterial strains were screened for the production of antifungal 
compounds. Genome mining allowed the discovery of the biosynthetic genes involved in 
the synthesis of the antifungal compounds hassallidin and anabaenolysin. Anabaena sp. 
SYKE748A produced more than 40 glycolipopeptide hassallidins in addition to the two 
main variants. Hassallidins were also identified from Aphanizomenon, 
Cylindrospermopsis, Nostoc and Tolypothrix species. The lipopeptides anabaenolysins 
were detected only in Anabaena strains. New variants of anabaenolysins C and D were 
chemically characterized. The antifungal activity of hassallidin D and anabaenolysin B 
were investigated through disc diffusion and microdilution bioassays. Synergistic 
antifungal activity was surprisingly observed through the production of anabaenolysin and 
cyclodextrins by Anabaena strains. 
 The macrolide scytophycin was identified from Anabaena strains in this study, the 
first report of scytophycin from this genus. In addition, Nostoc and Scytonema strains from 
benthic habitats in the Finnish coastal area in the Baltic Sea were found to produce 
scytophycins. Unidentified antifungal compounds from the strains Fischerella sp. CENA 
298, Scytonema hofmanni PCC 7110 and Nostoc sp. N107.3 were detected in the present 
study. Further chemical characterizations of these compounds are needed. 
 Cyanobacteria are a prolific source for bioactive compounds, which could be toxic 
or potentially new drug leads. In this study, we show evidence of cyanobacterial 
biosynthetic genes and their evolution. We also detected new variants of the 
cyanobacterial compounds and their bioactivity. Furthermore, this study showed the 













 Cianobactérias possuem uma longa história evolutiva datada em 3500 milhões de 
anos. Elas pertencem a uma antiga linhagem de bactérias fotossintéticas que contribuem 
para os ciclos globais de nitrogênio e carbono. As cianobactérias podem ser encontradas 
em diversos ambientes, de sistemas aquáticos a terrestres, com espécimes detectados e 
isolados de regiões geotérmicas, supersalinas, polares e desérticas. 
As cianobactérias são famosas pela produção de toxinas como microcistina, 
cilindrospermopsina, saxitoxina e anatoxina-a. Por outro lado, muitos compostos 
produzidos por essas linhagens apresentam atividades antibacterianas, antifúngicas, 
anticancerígenas, antivirais e antiprotozoáreas. Neste sentido, este estudo teve por objetivo 
investigar a evolução, a biossíntese, a variação química e a atividade antifúngica de 
substâncias bioativas produzidas por cianobactérias. 
 Os resultados indicam uma convergência na habilidade de cianobactérias, 
remotamente relacionadas, produzirem uma variante rara de microcistina. Microcistinas 
são geralmente produzidas por cianobactérias durante proliferações excessivas de células 
nos meios aquáticos, conhecidas como blooms. Porém, recentemente, microcistinas foram 
detectadas em linhagens bentônicas e associadas aos líquens. [D-Leu
1
] microcystin-LR foi 
encontrada em extratos celulares de uma linhagem bentônica, uma associada aos líquens e 
duas planctônicas. Análises bioinformáticas indicaram que eventos evolucionários 
diferentes, como, por exemplo, mutações pontuais e conversão de genes, estão envolvidos 
nessa convergência evolutiva. 
 Mais de 400 linhagens de cianobactérias foram testadas para a produção de 
compostos antifúngicos. A análise de genomas (genome mining) permitiu a descoberta dos 
genes envolvidos na síntese dos compostos antifúngicos hassalidina e anabaenolisina. 
Anabaena sp. SYKE748A produziu mais de 40 variantes do glicolipopeptídeo hassalidina, 
além das duas principais variantes. A produção de hassalidinas também foi detectada em 
linhagens dos gêneros Aphanizomenon, Cylindrospermopsis, Nostoc e Tolypothrix. O 
lipopeptídeo anabaenolisina foi detectado somente em linhagens do gênero Anabaena. As 
novas variantes de anabaenolisina C e D foram caracterizadas quimicamente. As 
atividades antifúngicas da hassalidina D e da anabaenolisina B foram investigadas através 
de ensaios de disco-difusão e microdiluição. Um aumento da atividade antifúngica foi 
observado com a ação conjunta de anabaenolisinas e ciclodextrinas produzidas por 
linhagens do gênero Anabaena. 
 O primeiro relato de produção do macrolídeo scitoficina por linhagens de 
Anabaena foi descrito neste estudo. Além disso, linhagens dos gêneros Nostoc e 
Scytonema, isoladas de ambientes bentônicos da costa finlandesa no Mar Báltico, foram 
descritas como produtoras de scitoficina. No mesmo estudo, foram descritos compostos 
não-identificados que apresentaram atividades antifúngicas, produzidos pelas linhagens 
Fischerella sp. CENA 298, Scytonema hofmanni PCC 7110 e Nostoc sp. N107.3. As 
caracterizações químicas destas substâncias bioativas precisarão ser realizadas no futuro. 
 Cianobactérias são uma fonte promissora de compostos bioativos que podem ser 
toxinas ou potencialmente novos medicamentos (drug leads). No presente estudo, 
mostramos evidências dos genes envolvidos nas sínteses, na evolução, na detecção de 
novas variantes e na bioatividade de compostos produzidos por cianobactérias. Além 








Syanobakteerien evolutiivinen historia kattaa kolme ja puoli miljardia vuotta 
maapallon olemassaolosta. Nämä fotosynteettiset bakteerit ovat vuosituhansien ajan 
edesauttaneet elämää toimimalla typen ja hiilen kierrättäjinä luonnossa. Syanobakteereja 
esiintyy mitä moninaisimmissa elinympäristöissä niin vesi- kuin maaekosysteemeissä. 
Joitain lajeja on havaittu ja eristetty elämän kannalta ääriolosuhteista – suolajärvistä, 
napaseuduilta, aavikoilta ja maankuoren geotermisen lämmön synnyttämistä kuumista 
lähteistä. Syanobakteerit ovat pahamaineisia tuottamiensa toksiinien johdosta. Tällaisia 
ovat esimerkiksi mikrokystiini, sylindrospermopsiini, saksitoksiini ja anatoksiini-a. 
Syanobakteerien on havaittu tuottavan muitakin yhdisteitä kuin toksiineja. Nämä yhdisteet 
tappavat ja estävät esimerkiksi bakteerien, sienien, syöpäsolujen, viruksien ja alkueläimien 
lisääntymistä ja toimintaa. Tämän työn tavoite on tutkia syanobakteerien tuottamien 
yhdisteiden evoluutiota, biosynteesiä, kemiallista vaihtelua ja antifungaalista aktiivisuutta.   
 Tulokset viittaavat siihen, että kaukaista sukua toisilleen olevat syanobakteerit ovat 
itsenäisesti, toisista erillään kehittäneet kyvyn tuottaa samaa mikrokystiinin harvinaista 
muotoa. Veden pintakerroksien planktiset syanobakteerit tuottavat mikrokystiiniä 
tavallisesti massaesiintymien aikana. Mikrokystiinejä on löydetty myös jäkälien 
symbioottisista ja vesistöjen pohjalla elävistä benttisistä syanobakteereista. Yhden, jäkälän 
kanssa symbionttisen, yhden benttisen sekä kahden planktisen syanobakteerikannan 
osoitettiin tuottavan [D-Leu
1
] mikrokystiini-LR:ää. Bioinformatiikka analyysit ilmaisivat, 
että syanobakteerien erilaisissa elinolosuhteissa syntynyt kyky tuottaa mikrokystiiniä on 
seurausta evolutionaarisista muutoksista esimerkiksi pistemutaation ja muun geenien 
muuntumisen kautta.   
 Antifungaalisia yhdisteitä tuottavien syanobakteerien löytämiseksi tutkittiin yli 400 
kantaa. Geenien analysointi paljasti biosynteesigeenit, jotka ovat vastuussa 
antifungaalisten yhdisteiden hassalidiinin ja anabaenolysiinin tuotannosta. Kahden 
päävariantin lisäksi Anabaena sp. SYKE748A tuotti yli 40 glykolipopeptidi hassallidiiniä. 
Hassalidiinejä tunnistettiin myös Aphanizomenon, Cylindrospermopsis, Nostoc ja 
Tolypothrix -lajeista. Lipopeptidi anabaenolysiinejä löydettiin vain Anabaena -kannoista. 
Kemiallisesti kuvattiin uudet anabaenolysiinit C ja D. Hassallidiini D:n ja anabaenolysiini 
B:n antifungaalista aktiivisuutta tutkittiin kiekkodiffuusio- ja 
mikrolaimennusbiotestimenetelmillä. Yllättäen Anabaena-kantojen havaittiin tuottavan 
samanaikaisesti sekä anabaenolysiiniä ja syklodekstriiniä ja jälkimmäisen havaittiin 
lisäävän anabaenolysiinin antifungaalista aktiivisuutta synergistisesti. 
 Tutkimuksessa tunnistettiin ensimmäisen kerran Anabaena -suvun kannoista 
makroliidi skytofysiiniä. Lisäksi Itämerellä, Suomen rannikon benttisten Nostoc ja 
Scytonema -kantojen havaittiin tuottavan skytofysiiniä. Tutkimuksessa löydettiin myös 
tuntemattomia antifungaalisia yhdisteitä Fischerella sp. CENA 298, Scytonema hofmanni 
PCC 7110 ja Nostoc sp. N107.3 kannoista. Näiden yhdisteiden tarkempi tunnistaminen 
vaatii lisätutkimuksia.  
 Syanobakteereista on löydetty runsaasti bioaktiivisia yhdisteitä, jotka ovat 
myrkyllisiä, mutta myös yhdisteitä joita voidaan mahdollisesti käyttää lääkkeiden lähteinä. 
Tässä tutkimuksessa tuotettiin uutta tietoa syanobakteerien biosynteesigeeneistä ja niiden 
evoluutiosta. Tutkimuksessa tuli esiin myös uusia syanobakteerien tuottamia yhdisteitä ja 
bioaktiivisuuksia. Lisäksi tutkimuksesta käy ilmi, kuinka syanobakteereja on mahdollista 









 Cyanobacteria are the only microorganisms capable of performing oxygenic 
photosynthesis. They can live in different types of environments, from aquatic (marine, 
brackish and freshwater) to terrestrial (rock, soil and lichen-association) habitats, 
including hypersaline, deserts, polar and hot springs (Whitton and Potts 2000, Stal 2012). 
Some of them have specialized cells, heterocysts, capable of fixing nitrogen, and resisting 
cells known as akinetes. However, some cyanobacteria, e.g. most of the oceanic nitrogen-
fixing cyanobacteria, can fix nitrogen without requiring the ability to form heterocysts 
(Díez et al. 2008, Tripp et al. 2010, Stal 2012). Gas vacuoles help planktonic 
cyanobacteria regulate their position in the water column through buoyancy. Hormogonia 
are motile filaments that can improve cyanobacterial dispersal and colonization (Meeks et 
al. 2002). Cyanobacteria are well known for their capability to produce bioactive 
compounds, an important feature that might improve their survival in the environment. 
More than 600 peptides or other molecules have been discovered in organisms from 




Natural products biosynthesis 
 
 Cyanobacterial natural products can be classified as peptides, polyketides, alkaloids, 
fatty acids, terpenes and UV-absorbing compounds (Micalleff et al. 2014). The synthesis 
of the cyanobacterial peptides occurs through ribosomal or nonribosomal pathways. 
Nonribosomal peptides and polyketides are synthesized by multifunctional modular 
enzymes known as nonribosomal peptide synthetases (NRPS) and polyketide synthases 
(PKS), respectively. These enzymes are formed by modules that incorporate each unit in 
the growing peptide (Figure 1). The elongation module of an NRPS is minimally 
composed by three domains: adenylation (A), peptidyl carrier protein (PCP) and 
condensation (C) (Marahiel and Essen 2009). The adenylation domain selects and 
activates the amino acid (Aa) that will be incorporated in the peptide (Finking and 
Marahiel 2004, Marahiel and Essen 2009). This amino acid is transferred to the peptidyl 
carrier protein and the condensation domain forms the peptide bond between two amino 
acids attached to the adjacent peptidyl carrier protein domain (Finking and Marahiel 2004, 
Marahiel and Essen 2009). An initiation module contains adenylation and peptidyl carrier 
protein domains (Finking and Marahiel 2004). The thioesterase domain (TE) catalyzes the 
possible formation of a macrocycle and the release of the compound (Marahiel and Essen 
2009). Tailoring domains might appear and they increase the diversity of possible 
modifications of the peptide. Among other tailoring domains, it is important to highlight 
the epimerization domain (E) that changes the L- to D-amino acids, methyltransferase 
(MT) that are responsible for the methylation of amino acid residues, and monooxygenase 
domains (OX) that incorporate one hydroxyl group to the substrate (Finking and Marahiel 
2004, Marahiel and Essen 2009). Glycosyltransferases are enzymes that add sugar units to 
free hydroxyl groups present in the peptide (Finking and Marahiel 2004, Welker and von 
Döhren 2006).  
 In a similar way, PKS-type I modules need a minimum of three domains: acyl-
transferase (AT), acyl carrier protein (ACP) and ketosynthase (KS) (Figure 1, Staunton 
10 
 
and Weissman 2001). The acyl-transferase selects one of these different units to be 
incorporated in the peptide malonyl-, methyl-, ethyl-, propylmalonyl-CoA (Coenzyme A) 
(Katz 1997). In a biosynthetic mechanism analagous to NRPS, the malonyl-CoA unit is 
transferred to the acyl carrier protein and subsequently the ketosynthase domain allows the 
formation of a bond between two units through Claisen-condensation. At the end of the 
elongation steps through all the PKS domains, the thioesterase domain (TE) cleaves and 
macrocyclizes the product. Optional domains can occur such as keto reductase (KR) 
(formation of hydroxyl groups), dehydratase (DH) (formation of unsaturated bonds) and 
enoyl reductase (ER) (reduction to saturated bonds) domains (Figure 1, Hopwood 1997, 
Katz 1997). Hybrid systems containing both NRPS and PKS domains are commonly 
involved in the synthesis of several compounds, such as microcystin from cyanobacteria 




Figure 1. Nonribosomal biosynthetic enzymes. A. Nonribosomal peptide synthetases (NRPS). 
B. Polyketide synthases (PKS). Domains showed in the figure: A- adenylation; PCP- peptidyl 
carrier protein; C- condensation; MT- methyltransferase; E- epimerization; AT- acyl-transferase; 
ACP- acyl carrier protein; KS- ketosynthase; KR- ketoreductase; DH- dehydratase; ER- enoyl 
reductase (Modified from Strieker et al. 2010 and Kehr et al. 2011). 
 
 
 Some nonribosomal peptides and polyketides have a fatty acid portion in their chemical 
structure. Fatty acid synthesis can occur in two different pathways: type I formed by large 
multifunctional proteins and type II formed by discrete proteins acting together (Campbell 
and Cronan 2001). The latter is more commonly found in bacteria and can be found as 
highly conserved protein sequences (Fab, fatty acid biosynthesis and Acc, acyl-CoA 
carboxylase) or the less conserved enoyl reductases (ER) (Campbell and Cronan 2001). 
Other proteins surrounding the previous ones are also involved in the fatty acid 
biosynthesis, such as acyl carrier protein (ACP) and biotin carboxyl carrier protein (AccB) 
(Campbell and Cronan 2001). 
11 
 
 The free fatty acids found in the cell can be activated to their corresponding coenzyme 
A derivatives by fatty acyl-CoA ligases (FACLs) to be further used in fatty acid transport, 
protein acylation, energy generation, phospholipid biosynthesis (Arora et al. 2009) and 
secondary metabolism (Miao et al. 2005). Fatty acyl-AMP ligases (FAALs) can form the 
fatty acyladenylates, which are the intermediary units for the coenzyme A derivatives 
(Trivedi et al. 2004, Arora et al. 2009). These activated fatty acyladenylates can be 
transferred to the acyl carrier protein to be used in the synthesis of lipidic compounds 
(Trivedi et al. 2004, Arora et al. 2009). 
 The fatty acid chain present in the secondary metabolites can also be formed by PKSs 
as in curacin A (Chang et al. 2004) or be incorporated by a starter condensation domain 
from NRPS that acts as an acceptor of a β-hydroxyl fatty acid (Rausch et al. 2007, Kraas 
et al. 2010, Qian et al. 2012). Several biosynthetic gene clusters have been described to 
contain these starter condensation domains, such as surfactin (Arima et al. 1968, Rausch et 
al. 2007), lichenysin (Horowitz and Griffin 1991), fengycin (Tosato et al. 1997), 
arthrofactin (Morikawa et al. 1993), polymyxin (Choi et al. 2009) and pelgipeptin (Qian et 
al. 2012). These different mechanisms can be used by cyanobacteria to synthesize 
lipopeptides. PuwC in the puwainaphycins biosynthetic gene cluster is a FAAL from 
Cylindrospermum alatosporum (Mareš et al. 2014). In the curacin A biosynthesis, CurG to 
CurM are polyketide modules that condensate seven malonyl-CoAs (Chang et al. 2004). 
Starter condensation domains have been described to be putatively involved in the 
synthesis of aeruginosin (Fewer et al. 2013), cyanopeptolin (Tooming-Klunderud et al. 
2007) and nostopeptolide (Hoffmann et al. 2003). 
 In addition to the possible incorporation of approximately 300 proteinogenic and 
nonproteinogenic substrates, different modification can be acquired with accessory 





Genetic diversity of cyanobacterial nonribosomal peptide and polyketide gene 
clusters 
 
 The nonribosomal pathways from cyanobacteria described to date are often large 
(between 11 to 63 kb) and most commonly consist of hybrid PKS/NRPS systems (Table 
1). Most known cyanobacterial gene clusters have been described for freshwater strains. 
The possibility of human poisoning due to water comsumption or recreation has focused 
the efforts to further study cyanobacterial toxins. The biosynthetic pathways of different 
cyanotoxins have been determined, such as microcystin, nodularins, cylindrospermopsins, 
anatoxin-a, and saxitoxins (Table 1, Dittmann et al. 2012). Marine filamentous 
cyanobacteria are a prolific source of drug leads, as almost 800 compounds have been 
described (Jones et al. 2010). Modifications increasing the diversity of cyanobacterial 
compounds can be obtained due to chlorination (anabaenopeptilide, curacin A, 
jamaicamides, hectochlorin and barbamide), bromination (jamaicamide A), methylation 
by methyltransferases in NRPS gene clusters and by S-adenosyl methionine (SAM)-
mediated methylation or HMGCoA-like β-branching mechanisms in PKS gene clusters 
(curacin A, barbamide and jamaicamide) and iodination (incorporation of iodine in the 
cryptophycin) (Rouhiainen et al. 2000, Jones et al. 2010, Kehr et al. 2011).  
 With the advance of next-generation sequencing methods, more genomes of 
cyanobacteria have been sequenced and are now available for analysis in the National 
12 
 
Center for Biotechnology Information (NCBI) database. The analysis of 991 organisms 
from the three domains of life showed high NRPS and PKS frequencies in Cyanobacteria, 
Proteobacteria, Actinobacteria, Firmicutes and Ascomycota (Wang et al. 2014). Another 
study indicates that 70% of 126 cyanobacterial genomes encoded NRPS or PKS gene 
clusters (Shih et al. 2013). From these 88 genomes, only 20% of the gene clusters were 
already known, with the other 80% (91 belonging to 19 cluster families) still needing 
further characterization (Calteau et al. 2014). Strains containing most of the NRPS or PKS 
gene clusters represented the following morphotypes: baeocystous (unicellular 
cyanobacteria that reproduce using multiple fissions in three planes), heterocystous 
(presence of specialized cell for nitrogen fixation) and ramified (filamentous cells that 
might divide to create branches) (Shih et al. 2013). Baeocystous strains are an under-
exploited interesting source of natural products.  
 The smallest cyanobacterial genome described to date has 1.44 mega base pairs (Mb) 
(marine cyanobacterium UCYN-A) and the largest has 12.07 Mb (Scytonema hofmanni 
PCC 7110) (Micallef et al. 2014). Genome mining will be essential for linking the 
metabolite to the biosynthetic gene cluster and in the near future it is likely to increase the 
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Evolution of the genes involved in the synthesis of nonribosomal peptides and 
polyketides 
 
  The presence of NRPS and PKS are energetically expensive for the microorganisms 
hosting these pathways. One example is the 15 000 amino acids present in the cyclosporin 
synthase to produce an undecapeptide (Amoutzias et al. 2008). This expensive synthesis 
system must be important for microorganisms to adapt or survive in the environment. 
However, it is believed that as soon as the synthesis of these nonribosomal peptides is not 
needed, the organism could perhaps lose the ability to produce it. It is therefore expected 
that the NRPS and PKS gene content would be modified based on their ecology 
(Amoutzias et al. 2008). Microcystin synthetase gene clusters are an example of this 
theory, in which the gene cluster is vertically transferred, rather than through horizontal 
gene transfer as earlier hypothesized (Rantala et al. 2004). The ability to produce 
microcystin has been lost by some genera of cyanobacteria and explains why we 
occasionally find the genes. There is additionally an indication that the biosynthetic genes 
involved in the synthesis of nodularin (a chemically related compound) have been derived 
from the microcystin gene cluster (Rantala et al. 2004, Moffitt and Neilan 2004). 
Nevertheless, a recent broad comparative study in the cyanobacterial phylum level 
indicates that most of the NRPS/PKS gene clusters are not vertically inherited or obtained 
through horizontal gene transfer (Calteau et al. 2014). Most of the gene clusters analyzed 
showed a more complex evolutionary history.  
 Studies have shown that recombination and point mutations in the domains responsible 
for the selection and activation of subunits (adenylation and acyl-transferase domains) 
increases the diversity of the peptides produced (Jenke-Kodama et al. 2006, Fewer et al. 
2007). The incorporation of a diverse number of substrates in NRPS and rapid evolution 
resulting in high diversity of peptide synthesis might be the advantages of keeping these 
energetically costly modular NRPS and PKS systems (Amoutzias et al. 2008). 
Nonetheless, the selective value of these NRPS and PKS systems for cyanobacteria 
remains unclear. 
 The recombination events occuring in the adenylation domain gene sequences result in 
incongruent phylogeny compared to the evolutionary history of the organism harbouring 
the biosynthetic pathway. However, the analysis based on the alignment of amino acid 
sequences helps predict the amino acid substrate to be activated and incorporated in the 
growing peptide by the adenylation domain. The prediction of the activated amino acid is 
based on the identification of ten amino acid residues (binding pocket) based in the 
position of core motifs (Stachelhaus et al. 1999) or 34 residues at 8 Å distant from the 
substrate (Rausch et al. 2005, Jenke-Kodama and Dittmann 2009). It was also shown that 
two point mutations in the binding pocket were sufficient to change the adenylation 
domain specificity from phenylalanine to leucine (Stachelhaus et al. 1999). A higher 
diversity of peptides could be obtained by mutations and gene conversions of the 
adenylation domains, allowing e.g. for a change in the peptide activity. 
 In contrast to adenylation domains, phylogenetic studies based on condensation domain 
sequences show congruence in the phylogenetic trees (Rausch et al. 2007). These authors 
additionally provided profiles of domain sets (hidden Markov model – HMM) to help in 
the classification of an unknown condensation domain. The known condensation domains 
are divided into the following subtypes: 
L
CL (forms the peptide bond between two 
adjacents L-amino acids), 
D
CL (forms the peptide bond between one L-amino acid and an 
oligopeptide with a D-amino acid at the end, and is usually present after an epimerization 
domain in the gene cluster), cyclization (condensation and cyclization of the oligopeptide), 
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starter condensation (acylates with a fatty acid the first incorporated amino acid) and dual 
epimerization (responsible for epimerization and condensation) (Rausch et al. 2007). 
Phylogenetic analysis combined with functional data and bioinformatics can also be used 
to predict whether an acyl-transferase domain in PKS will recognize malonyl-CoA or 
methylmalonyl-CoA (Amoutzias et al. 2008). Different programmes and databases 
available for NRPS and PKS analyses are useful. However, caution should be excercized 
concerning possible unfunctional domains and systems not following the colinearity rule 
(Jenke-Kodama and Dittmann 2009). 
 Studies on the evolutionary history and the function of these NRPSs and PKSs increase 
the chance for successful modifications of biosynthetic pathways and help genome mining 




Activity of cyanobacterial nonribosomal peptides and polyketides 
 
 Cyanobacteria are present in diverse environments and are able to produce natural 
products. Strains living in fresh- and brackish water in tropical regions as well as others 
living in meltwater ponds in the Antarctic were found to produce microcystin (Hitzfeld et 
al. 2000, Welker and von Döhren 2006, van Apeldoorn et al. 2007). While a broad global 
distribution of cyanobacterial strains can be seen, it is common to find microcystin-
producing and non-producing cyanobacteria growth in the same bloom sample (Vezie et 
al. 1998, Janse et al. 2004). Microcystin has been largely studied due to toxic effects in 
humans and animals. It is a cyclic heptapeptide produced by a hybrid system of NRPS and 
PKS (Tillett et al. 2000). Microcystin inhibits the protein phosphatases 1 and 2A in the 
hepatocytes, which may result in haemorrhaging or liver failure (van Apeldoorn et al. 
2007, Campos and Vasconcelos 2010). Although microcystin can affect its predator 
Daphnia (Rohrlack et al. 1999), no clear evidence was found that this intoxication could 
change zooplankton dynamics (Martins and Vasconcelos 2009). 
 A variety of cyanobacterial natural products have been reported to have allelopathic 
activity, inhibiting other cyanobacteria, micro- and macro-algae and angiosperms (Leão et 
al. 2009). Nostocyclamide is produced by the freshwater strain Nostoc sp. 31 and inhibits 
cyanobacteria and algae (Todorova et al. 1995). Portoamides A and B, from a freshwater 
Oscillatoria sp. differ by one O-methyl group, showed a synergistic allelopathic effect 
inhibiting the micro-algae Chorella vulgaris (Leão et al. 2010). Other possible ecologic 
roles for the cyanobacterial compounds are resource competition (e.g. metal chelators), 
quorum sensing or intracellular physiology (Utkilen and Gjølme 1995, Kaebernick et al. 
2000, Dittmann et al. 2001, Leão et al. 2012, Neilan et al. 2013, Pereira and Giani 2014). 
However, the function of these molecules for the cyanobacteria is still unknown but might 
provide an advantage in the ecosystems such as defense, allelopathy or fitness 
enhancement (Schatz et al. 2007, Sivonen 2009, Méjean and Ploux 2013, Meissner et al. 
2014). 
 While this issue is not uncovered, natural products produced by cyanobacteria are 
recognized as toxins or potential drug leads. Microcystins, nodularins, 
cylindrospermopsins, anatoxin-a and saxitoxins are infamous for their hepato- or 
neurotoxicity to human cells. Cyanobacteria present in water used for human consumption 
or recreation should be monitored due to the potential synthesis of one or more of these 
cyanotoxins. However, other compounds produced by cyanobacteria present 
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pharmaceutical interest for their anticancer, antiviral, antimicrobial and protease inhibition 
activity (Singh et al. 2011). 
 Promising anticancer agents from cyanobacteria are e.g. cryptophycin from Nostoc sp., 
curacin A from Lyngbya majuscuala, dolastatin from Symploca sp. and Lyngbya sp., 
apratoxin A from Lyngbya sp., tolyporphin from Tolypothrix nodosa and 
somocystinamide from Lyngbya majuscula (Singh et al. 2011). Although the clinical trials 
of cryptophycin and dolastatin were discontinued, their analogues cryptophycin 249 and 
309 and ILX-651 (synthadotin) still represent a hope for new trials (Singh et al. 2011). 
 Some interesting compounds with bioactivity include anabaenolysins A and B, which 
are lipopeptides found in benthic Anabaena sp. (Jokela et al. 2012), and potent cytotoxins 
able to permeate mammalian cells that contain cholesterol (Oftedal et al. 2012). 
Scytophycins are macrolide polyketides produced by Scytonema (Carmeli et al. 1990a), 
Tolypothrix (Ishibashi et al. 1986), Cylindrospermum (Jung et al. 1991) and Nostoc 
(Tomsickova et al. 2014) strains that present strong antifungal and anticancer activities 
(Ishibashi et al. 1986, Yeung and Patterson 2002). 
 In 2014 The World Health Organization (WHO) published its first report on the 
surveillance of antimicrobial resistance. This warning comes during a time when we face a 
globally distributed increase in the resistence to commonly used antimicrobial compounds 
combined with a lack of new approved antimicrobial drugs. Only three classes of 
antifungal compounds (azoles, echinocandins and polyenes) are available to treat serious 
infections caused by Candida spp., and problems such as high toxicity, increased 
resistence, high costs and absence of oral formulation deepens this difficult situation 
(WHO 2014). Some cyanobacterial antifungal compounds are listed in Table 2. There are 
a variety of compound classes with antifungal activity, but several of these discovered 




Table 2. Examples of antifungal compounds from cyanobacteria (Modified from Abed et al. 
2008 and Chlipala et al. 2011). 
Chemical class Compound family Strains of cyanobacteria Reference 
Alkaloid Ambiguine isonitriles Fischerella ambigua, 
Fischerella sp. 
Raveh and Carmeli 2007, 
Smitka et al. 1992 
 Carazostatin Hyella caespitose Burja et al. 2001 
 Fischerellin Fischerella muscicola Dahms et al. 2006  
 Fischerindoles Fischerella muscicola Park et al. 1992 
 Hapalindole Hapalosiphon fontinalis Burja et al. 2001 
 Norharmane Nodularia harveyana Volk and Furkert 2006 
 Tjipanazoles Tolypothrix tjipanasensis Bonjouklian et al. 1991, 
Falch et al. 1995 
 Welwitindolinones Hapalosiphon welwitschii, 
Westiella intricate 
 
Stratmann et al. 1994a 
Aromatic Ambigols A-C Fischerella ambigua Wright et al. 2005,  
Falch et al. 1993, 1995 
 Cyanobacterin Scytonema hofmannii 
 
Lee and Gleason 1994, 
Pignatello et al. 1983 
Cyclic peptide AK-3 Synechocystis sp. Yoon and Lee 2009 
 Laxaphycins A and B Anabaena laxa 
Lyngbya majuscula 
Bonnard et al. 1997, 
Frankmölle et al. 1992a,b 
 Nostocyclamide Nostoc sp. Abed et al. 2008 
 Tolybyssidins A and B Tolypothrix byssoidea Jaki et al. 2001 
20 
 
Chemical class Compound family Strains of cyanobacteria Reference 
Lipopeptide Balticidins Anabaena cylindrica Bui et al. 2014 
 Calophycin Calothrix fusca Moon et al. 1992 
 Hassallidin Hassallia sp. Neuhof et al. 2005, 2006a 
 Lobocyclamides Mat containing Lyngbya 
confervoides 
MacMillan et al. 2002 
 Nostofungicidine Nostoc commune Kajiyama et al. 1998  
 Scyzotrin A Schizothrix sp. Pergament and Carmeli 
1994 
 Scytonemin Scytonema sp. 
 
Helms et al. 1988 
Nucleoside Toyocamycin Tolypothrix tenuis 
 
Banker and Carmeli 1998, 
Stewart et al. 1988 
Oligosaccharide Nostodione Nostoc commune 
 
Bhadury and Wright 2004 
Phenolic 4,4´-dihydroxybiphenyl Nostoc insulare 
 
Volk and Furkert 2006 
Polyketide Cryptophycin Nostoc sp. Schwartz et al. 1990 
 Mirabilene isonitriles A-F Scytonema hofmannii Carmeli et al. 1990b 
 Scytophycins Scytonema 
pseudohofmanni 
Burja et al. 2001 
 Tolytoxin Tolypothrix conglutinata 
var. Colorata 
 
Carmeli et al. 1990a 
Volatile alkane Tetradecane, heptadecane Spirulina platensis Ozdemir et al. 2004 
 
 
 Curiously, the analysis of a marine compounds database (MarinLit) from cyanobacteria 
showed that 40% of the cyanobacterial natural products were lipopeptides (Burja et al. 
2001). Among these 170 cyclic and linear lipopeptides, 85% presented some bioactivity: 
cytotoxic, antiviral, anticancer, antifungal, antibacterial, enzyme inhibitor or other (Burja 
et al. 2001). Some examples of the lipopeptides are presented in Table 3. These 
compounds present different lengths of the fatty acid chain and different activities. The 
majority of the compounds are synthesized by marine Lyngbya spp. It is interesting to note 
the huge variation in chemical structures of the different compounds (Table 3). The 
pharmaceutical interest in the lipopeptides is due to their capability to pass the blood-
tissue and blood-brain barrier because of their interaction with cell liposomes and 
membranes (Burja et al. 2001).  
 Glycolipopeptides are lipopeptides containing sugar chains, such as hassallidins A and 
B, which are antifungal glycosylated lipopeptides isolated from Hassallia sp. extracts 
(Table 3, Neuhof et al. 2005, 2006a). The mechanism of action of hassallidin A is to affect 
the integrity of Candida albicans plasma membrane (Neuhof et al. 2006b). Suomilides are 
glycolipopeptides produced by Nodularia spumigena HKVV (Fujii et al. 1997) and belong 
to the aeruginosin family of protease inhibitors (Schindler et al. 2008). Other previously 
described compounds containing a sugar chain in the structure include 
bacteriopanepolyols (terpenoid), malyngamide J (glycolipid), lyngbyaloside (polyketide), 
malyngamides-type alkaloids and tolyporphins (porphinoid) (Tidgewell et al. 2010). 
Known cyanobacterial compounds composed of only carbohydrates are the 
iminotetrasaccharide from Anabaena sp. that have moderate inhibitory activity of β-D-
glucuronidase, and the cyclodextrins from Tolypothrix byssoidea that blocks the activity 
of other compounds produced by this strain (Tidgewell et al. 2010). 
 Screenings, such as the one performed in this present doctoral thesis, are urgently 
needed to detect new or synthetically modified bioactive compounds, and cyanobacteria 
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have proved to be a prolific source for different and complex compounds. The discovery 
of new chemical structures that present bioactivity is the first, and very important, step of 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Drug discovery and development process 
 
 There is a constant need for more efficient and effective drugs to combat diverse 
diseases or clinical conditions and improve the quality of life for mankind. The process of 
drug discovery and development until the final approval of a product for marketing can 
take more than 12 years at a cost of over $ 1 billion (Gad 2005, Hughes et al. 2011). The 
drug discovery process begins with screening for bioactive compounds, their mechanism 
of action and the optimization of the compound’s activity and efficacy (Figure 2). After 
the selection of the best candidates, the compounds are tested on animal models during the 
preclinical trials to evaluate if the drug is safe to be tested on humans. The next step is to 
test the drug on humans during three-phased clinical trials (Figure 2). The aims of the 
clinical trials are to evaluate the safety and effectiveness of the compound. The results 
obtained will be reviewed by different agencies that will decide if the drug can be 
commercialized (Figure 2). The Food and Drug Administration (FDA) agency in the 
United States and the European Medicines Agency (EMA) of the European Union are 
examples of regulatory agencies that approve new drugs. The large-scale manufacture of a 
compound will be evaluated during the FDA review and might be a reason for any delay 
in the approval or denial of the drug’s commercialization. The FDA will continue to 




Figure 2. Drug discovery and development process. The average time spent on each phase is 
indicated below the rectangle. An asterisk (*) indicates the part of the process in which this 
doctoral thesis is involved. 
 
Nearly half of the new drugs introduced in the marked during the period of 1981–2002 
were natural products or semi-synthetic and synthetic compounds based on natural 
products (Koehn and Carter 2005). The interest of the research for new drug leads from 
natural products relies on the high chemical diversity and novelty found in these sources 
(Spainhour 2005). However, a decrease in pharmaceutical company investments in the 
discovery of natural products, especially related to infectious disease therapy, has been 
observed in past years (Koehn and Carter 2005). WHO has contradictingly warned of an 
increase in antimicrobial resistance indicating an urgent need for finding new 
antimicrobial drugs (WHO 2014). Advances obtained in synthetic chemistry (for the 
synthesis of complex natural products), modelling (of compounds and their targets to 
improve their activities) and combinatorial synthesis (to increase the diversity of 
compounds to be tested) (Koehn and Carter 2005) improve the success of finding new 
drugs based on natural products. The FDA and EMA have applied new facilitating 
measures in 2012 for antibiotic development that are leading to an increase in the research 
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of antimicrobial peptides by small companies (Fox 2013). This action is refuelling 
antimicrobial research and showing a new hope for the future.  
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2. Study aims 
 
Genes involved in the synthesis of cyanobacterial bioactive peptides and their 
evolutionary origins were investigated, while the chemical characterizations of the 
compounds related to the biosynthetic genes were analyzed and their bioactivities were 
tested.  
 
The specific aims of this doctoral thesis were: 
- to study the evolutionary history of a rare microcystin hepatotoxin based on mcy 
biosynthetic genes (I) 
- to describe the hassallidin gene cluster and the chemical variants produced by 
different cyanobacteria (II) 
- to detect cyanobacteria producing the cytotoxin anabaenolysin, to analyze its 
biological activity and to describe the gene cluster involved in anabaenolysin 
synthesis (III) 

































3. Summary of material and methods 
 
 The cyanobacterial strains used in the articles (I, II, III and IV) included in this doctoral 
thesis are listed in Supplementary Table S1. The methods used in each study are explained 
in detail in the articles. The different methods used in each article are indicated in Table 4. 
 
 
Table 4. Methods used in this thesis. 
 
Method Described in 
Cultivation of cyanobacterial strains 
 
I, II, III, IV 
Molecular biology analysis 
 DNA extraction I, II, III, IV 
 PCR amplification I, II, III, IV 
 Cloning I, II, III, IV 
 Sequencing I, II, III, IV 
 Site-directed mutation I 








 Phylogenetic analyses I, II, III, IV 
 Recombination test I 
 Identification of gene cluster II, III 
 Substrate prediction of adenylation domains 
  
I, II, III 
Chemical analysis  
 LC-MS I, II, III, IV 
 Purification of compounds I, II, III, IV 





 Amino acid analysis I, II, III 
 NMR 
 
II, III, IV 
Bioactivity  
 Preparation of crude extracts II, III, IV 
 Disk diffusion assay II, III, IV 









4. Summary of results and discussion 
 
Anabaenolysin, hassallidin and microcystin gene clusters (I, II, III) 
 
 Cyanobacteria can produce different bioactive compounds through ribosomal or 
nonribosomal pathways. Figure 3 shows the genes and enzymes involved in the synthesis 
of three bioactive compounds investigated in this study. The present study described two 
new nonribosomal gene clusters involved in the synthesis of anabaenolysins and 
hassallidins (Figure 3A and B).  
 The 23–24.3 kilo base pairs (kb) anabaenolysin gene cluster (abl) was located in the 
genomes of Anabaena spp. XSPORK2A, XPORK13A and XPORK15F, and predicted to 
be involved in the synthesis of anabaenolysin. The partial genomes of three Anabaena 
strains producing anabaenolysin B or C were obtained to unveil the biosynthetic genes of 
these compounds. The abl gene cluster consists of a hybrid NRPS and PKS, with 
additional enzymes such as the FADS (fatty acid desaturase) and a hypothetical protein. 
The NRPSs (AblA, AblD and AblE) contain three adenylation domains, which are 
predicted to activate and incorporate one aspartic acid and two glycines to anabaenolysin 
B. Anabaena sp. XPORK13A produces anabaenolysin C and the adenylation domain in 
the NRPS AblD activates and incorporates a glutamine instead of glycine. The FADS 
(AblC) might act in the creation of double bonds in the fatty acid chain and the PKS 
(AblB) in the addition of one malonyl-CoA unit and a hydroxyl group after the modified 
aspartic acid. Enzymes involved in the synthesis of the fatty acid chain and its 
incorporation in the anabaenolysin were not detected close to the putative gene cluster. 
However, two (XPORK13A and XPORK15F) or three (XSPORK2A) FAALs were 
detected elsewhere in the three genomes analyzed (III). 
NRPSs and tailoring enzymes constitute the 59 kb biosynthetic pathway of hassallidin 
(has) (II). Nine amino acids are activated and incorporated in the hassalliding by nine 
NRPS modules. Enzymes were found to be involved in the incorporation of fatty acid 
(acyl-protein synthetase, ligase and acyl carrier protein), sugars (glycosyltransferases), the 
acetylation of a sugar (acetyltransferase) and in the synthesis of the fatty acid chain (3-
oxoacyl-acyl-carrier-protein). Interestingly, this gene cluster was found to be responsible 
for the synthesis of more than 40 different variants of hassallidins in Anabaena sp. SYKE 
748A. The genome of Anabaena sp. 90 contained a putative hassallidin gene cluster 
(Wang et al. 2012). However, the deletion of 526 bp in the condensation domain of hasV 
turned into an inactive gene cluster, and this strain is no longer a producer of hassallidin 
















































































































































































































































































































Microcystins are synthesized by a hybrid NRPS and PKS system first described in 
Microcystis aeruginosa PCC 7806 (Figure 3C, Tillett et al. 2000). The microcystin 
biosynthetic genes of Anabaena, Plankthotrix and Nostoc have been described before 
(Christiansen et al. 2003, Rouhiainen et al. 2004, Fewer et al. 2013). The present study 
focused on the analysis of microcystin genes, specifically the region of the McyA 
responsible for the incorporation of the amino acid in position one of the microcystin (I). 
The knowledge of the biosynthetic genes involved in toxin synthesis e.g. microcystin, 
improved the molecular methods for the detection of potential toxin producers in 
environmental samples (Dittmann et al. 2012).  
Knowledge of the enzymes involved in the synthesis of nonribosomal peptides 
additionally collaborates with further modifications in this system to improve production 
or modify the final product. The number of genome sequences from cyanobacteria 
available in databases, e.g. NCBI, is increasing. Currently there is an interest to link the 
information in the genome with the compounds produced by each strain. This study has 
succeeded in presenting two new biosynthetic gene clusters involved in the synthesis of 




Gene evolution involved in microcystin and anabaenolysin synthesis (I, III) 
 
Cyanobacteria are ancient microorganisms and the selective forces leading to the 
evolutionary history of the NRPS and PKS genes are still not fully understood. 
Microcystin is a hepatotoxin produced by diverse cyanobacteria. They can be widely 
detected in strains from fresh- or brackish water, and cyanobacteria in lichen symbiosis 
(Sivonen and Jones 1999; Sivonen 2009, Lopes and Vasconcelos 2011, Kaasalainen et al. 
2012). It was previously hypothesized that microcystin biosynthetic genes were 
horizontally transferred, and were later found to be more ancient in cyanobacteria (Rantala 
et al. 2004, Dittmann et al. 2012). Some cyanobacteria may have lost the mcy genes, while 
others may have experienced different selective forces (e.g. recombination) that allowed a 
huge diversity of microcystins to be synthesized by different strains. In the present study, 
the production of a rare variant of the hepatotoxin microcystin was found to be the result 
of convergent evolution in three distantly related cyanobacteria (I). The phylogenetic and 
recombination analyses indicated that the filamentous strains Nostoc sp. UK89IIa and 
Phormidium sp. CENA270 suffered gene conversion, while the unicellular strains 
Microcystis spp. NPLJ-4 and RST 9501 had point mutations in the mcyA gene (Figure 4 
and I). Phylogenetic analysis revealed that these gene conversions and point mutations 
resulted in the synthesis of the same [D-Leu
1
]microcystin-LR variant by the studied 
strains (I). The evolutionary history based on genes involved in the microcystin synthesis 
(mcy) indicated recombination in the adenylation domain gene regions, but not in the other 
domains (condensation, peptidyl carrier protein and epimerization domains) (I). 
Recombination and positive selection in the adenylation domains of McyB and McyC has 
been related to the high variability of amino acids found in position 2 of the microcystins 
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(Mikalsen et al. 2003, Kurmayer et al. 2005, Fewer et al. 2007, Tooming-Klunderud et al. 
2008, Christiansen et al. 2008). In this study (I), we show that McyA is also under 
recombination, which resulted in a rare variation in position 1 of the microcystin. The 
study of the enzymes involved in the synthesis of NRPSs and PKSs might contribute to 
further engineering and heterologous expression of new or known compounds. The results 
in study (I) indicates that the replacement of the entire adenylation domain, rather than 
using point mutations, could be a more efficient strategy for obtaining more specificity in 




Figure 4. Independent evolutionary history of the McyA2 adenylation domain. Maximum-
likelihood tree based on amino acid sequences inferred using MEGA 5. Bootstrap values above 50 
per cent from 1000 respectively neighbour-joining, maximum parsimony and maximum-likelihood 
bootstrap replicates are given at the nodes. The studied strains are marked in bold and indicated 
with *. (From article I). 
 
 
The gene cluster involved in the synthesis of the lipopeptide anabaenolysin is a hybrid 
of NRPS and PKS (III). A phylogenetic tree was obtained using the condensation domain 
sequences belonging to the anabaenolysin gene cluster. AblD and AblE grouped with 
other condensation domains that form the peptide bonds between two L- amino acids 
(
L
CL) (III). However, AblA and other condensation domains present in hybrid NRPS/PKS 
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systems were grouped together, and have in common an aminotransferase and/or a 
monooxigenase preceding them (III).  
Interestingly, most of the 452 gene clusters from cyanobacteria recently analyzed 
presented a more complex evolutionary history than the vertical or horizontal gene transfer 
(Calteau et al. 2014). Different evolutionary mechanisms might be involved in the final 
gene cluster (Dittmann et al. 2012, Calteau et al. 2014). 
The evolutionary history of the different enzymes involved in nonribosomal 
biosynthesis helps to understand their organization and function in the unknown natural 
products gene clusters. A better understanding of highly recombinant regions in these 
genes might help lead to the rational modification of these systems according to an interest 




Diversity of cyanobacterial strains producing the studied natural products (I, II, III, 
IV) 
 
Natural products produced by cyanobacteria can be divided into different classes such 
as peptides, alkaloids, macrolides, fatty acids and indoles (Burja et al. 2001). Table 5 
summarizes the compounds detected in this study to be produced by each genus of 
cyanobacteria.  
 
Table 5. Compounds detected in different genera of cyanobacterial crude extracts. 



























































Anabaena  + + + +  II,III,IV 
Aphanizomenon  +     II 
Cylindrospermopsis  +     II 
Microcystis +      I 
Fischerella      + IV 
Phormidium +      I 
Nostoc + +   + + I,II,IV 
Scytonema     + + IV 
Tolypothrix  +     II 
 
Microcystis spp. from brackish water, a Nostoc sp. in lichen-association and a 
Phormidium sp. from freshwater were found to produce the same rare variant [D-
Leu
1
]microcystin-LR (I). The Microcystis strains were found to also produce 
[Met
1
]microcystin-LR (I). Although Microcystis sp. RST 9501 produced higher amounts 
of [Met
1
]microcystin-LR, the strain Microcystis aeruginosa NPLJ-4 could produce more 







Most of the microcystins detected in previous studies have an alanine in position one 
(Sivonen and Jones 1999). This study (I) was the first description of a microcystin 
containing methionine in this position. Leucine (Leu or L) (Matthiensen et al. 2000, Park 
et al. 2001, Schripsema and Dagnino 2002, Albuquerque et al. 2007, Kaasalainen et al. 
2012), glycine (Wood et al. 2008) and serine (Sivonen et al. 1992, Oksanen et al. 2004) 
have previously been reported. Interestingly, methionine (Met) is not commonly found in 
secondary metabolites (Caboche et al. 2010), and this could be due to the highly active 
sulfhydryl group. Microcystins have mainly been detected in planktonic strains, where the 
most common producers are Microcystis, Planktothrix and Anabaena (Sivonen 2009). 
However, benthic and terrestrial specimens are also able to produce microcystins 
(Izaguirre et al. 2007, Sivonen 2009, Kaasalainen et al. 2012). 
Cyanobacterial strains isolated from aquatic (fresh- and brackish water) and terrestrial 
(lichen-association and rocks) were described to produce hassallidins (II, IV). The 
Anabaena sp. SYKE 748A was found to produce a huge number of hassallidin variants 
(II). The hassallidins detected in this study varied regarding the size of the fatty acid chain, 
the amino acid present in position ten (glutamine (Q), tyrosine (Y) or threonine (T)), the 
sugars and their amounts present in the structure and the acetylation present in the hexose 
(Table 6). 
 
Table 6. The structural variation of hassallidins in strains of cyanobacteria from Anabaena, 
Nostoc, Aphanizomenon, Tolypothrix and Cylindrospermopsis genera. Variation in aglyconic 
lipopeptides (A-M) can be explained by the hydrocarbon chain length (Cn = 14 -18, U = unknown) 
of the di-OH-fatty acid in position 1 and by amino acids in position 10 (Aa
10
; Q = glutamine, Y = 
tyrosine, X = unknown amino acid). Monosaccharides M1, M2 and M3 of hassallidins are N-
acetylhexosamine (▲), pentose (▼), deoxyhexose (♦) and hexose (●), which contains 0–4 acetyl 
(Ac) groups. Monosaccharide positions have been deduced based on the identified positions in 





Code*: A B C D E F G H I J K L M 
 
M1 M2 M3 (Hex) 
         Cn: 14 15 16 18 14 15 16 18 18 U U U U 
 
  0 - 4 = no of Ac 
Genus            Aa10 : Q Q Q Q Y Y Y Y T X X X X     0 1 2 3 4 
Anabaena ■ ■ ■ ■ ■ ■ ■ ■   ■  ■    ■ 
 




        
■ ■ 
 
▲ ● ▼ ♦ ● 
    
Aphanizomenon                         ■   ▼ ▼   ● ●     
Tolypothrix 
        
  
   
■ 
 
● ▼ ♦ ● 
    
Cylindrospermopsis       ■         ■             ▼ ●         
*A-M: 1220, 1234, 1248, 1276, 1255, 1269, 1283, 1311, 1249, 1232, 1241, 1282, 1298 m/z. 
 
 
Hassallidins A and B have first been described in Hassallia sp. (Neuhof et al. 2005, 
2006a). The present study was able to detect the production of hassallidins by different 
cyanobacteria, including bloom-forming strains such as Anabaena and Cylindrospermosis 
(II and IV). Aphanizomenon, Nostoc and Tolypothrix are also among the hassallidin 
producers (Table 5). Twenty-two isolated Anabaena strains producing hassalidins were 
detected (II and IV). Balticidins, compounds very similar to hassallidins, were recently 
detected in Anabaena cylindrica Bio33 isolated from the Baltic Sea (Bui et al. 2014). In 
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addition to the cyclic forms, hassallidins and balticidins (Bui et al. 2014) can also be 
detected in linear forms in the extracts, which indicate that the rings of these compounds 
are unstable.  
Anabaenolysins were detected only in Anabaena species (III). Most of the Anabaena 
strains producing anabaenolysins are grouped together in the phylogenetic tree, except 
Anabaena sp. XPORK15F (Figure 3 in III). All the anabaenolysin producers were isolated 
from brackish water in the Finnish coastal area. Anabaenolysins were first reported a few 
years ago in two benthic strains isolated from the Baltic Sea (Jokela et al. 2012). New 
variants of anabaenolysin C and D have been discovered in the present study (III). These 
new variants have a glutamine instead of a glycine in position three of the anabaenolysin. 
The two new variants differ from each other by one double bond in the fatty acid (III). 
Anabaena strains are also known to produce other lipopeptides such as hassallidins 
(Neuhof et al. 2005, 2006a and studies II and IV), puwainaphycins (Moore et al. 1989a, 
Hrouzek et al. 2012), laxaphycins (Frankmölle et al. 1992a,b), spiroidesin (Kaya et al. 
2002), minutissamides (Kang et al. 2011, 2012) and balticidins (Bui et al. 2014).  
Anabaena strains producing anabaenolysins were also found to produce di- and tri-
acetylated α-, β- and/or γ-cyclodextrins (III). These cyclodextrins have six, seven or eight 
hexoses that are decorated with two to three acetyl groups. Interestingly, cyclodextrins are 
cyclic oligosaccharides that can form complexes and are used to improve the solubility of 
hydrophobic compounds (Nardello-Rataj and Leclercq 2014). Cyclodextrins have a 
conical shape and commonly have six (α-), seven (β-) or eight (γ-) glucose units 
(Nardello-Rataj and Leclercq 2014). Cyclodextrins are used in the pharmaceutical industry 
for drug delivery, the encapsulation of biocides and in food and cosmetics products 
(Szejtli 1998, Astray et al. 2009, Ruiz et al. 2014, Nardello-Rataj and Leclercq 2014).  
Scytophycin is a macrolide, which contains a macrocyclic lactone ring. It has been 
discovered in Scytonema spp. (Ishibashi et al. 1986, Carmeli et al. 1990a) and later 
detected in Nostoc sp. (Tomsickova et al. 2013). In this study, we found new and known 
scytophycin variants being produced from Anabaena, Nostoc and Scytonema (IV). This is 
the first report of Anabaena strains producing scytophycins. Several compounds have 
been described as structurally related to scytophycins, e.g. tolytoxin (Carmeli et al. 1990a, 
Ishibashi et al. 1986), swinholides, aplyronine, sphinxolides/reidispongiolides and 
ulapualides/kabiramide/halichondramides/mycalolides (Yeung and Paterson 2002). 
Interestingly, these related compounds were detected in cyanobacteria, sea hare, sponges 
and their symbionts, nudibranches and coral (see discussion in IV). 
Three cyanobacterial strains were detected to show antifungal activity in their crude 
methanol extract:  Fischerella sp. CENA 298, Scytonema hofmanni PCC 7110 and Nostoc 




Activity of cyanobacterial natural products analyzed in this study (II, III, IV) 
 
This study detected known and unidentified antifungal compounds produced by 
cyanobacteria. Hassallidin D produced by Anabaena sp. SYKE748A had a minimum 
inhibitory concentration (MIC) of ≤ 2.8 µg/mL (1.5 µM) against Candida albicans (II). 
Interestingly, the linear form of hassallidin D had an MIC of 36 µg/mL (20 µM) (II). The 
linear hassallidin was less potent than the cyclic version, but nevertheless it was still active 
against Candida albicans. Compounds might usually lose practically all of their activity 
when linearized (Choi et al. 1993, Herfindal et al. 2011).  
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Isolated anabaenolysin B from Anabaena sp. XSPORK27C did not show strong 
inhibition to Candida albicans (MIC of 1.47 mg ml
-1
 and a half maximum inhibitory 
concentration or concentration at 50% inhibition (IC50) of 1.15 mg ml
-1
; 2.1 mM). 
However, when combined to a mixture of di- and tri-acetylated α-, β- and γ-cyclodextrins 
produced by anabaenolysins producers, the antifungal activity was improved (IV). 
Cyclodextrins are known to form complexes with diverse compounds to improve their 
solubility. Fatty acid synthesis can be stimulated in the presence of cyclodextrins in 
Mycobacterium phlei (Machida et al. 1973). This complex cyclodextrin-fatty acid would 
avoid a high number of free fatty acids and stimulate the cell to continue its production 
(Machida et al. 1973). A complex formed of cyclodextrin and tolypophycins produced by 
the cyanobacterium Tolypothrix byssoidea blocked the antifungal activity (Entzeroth et al. 
1986). However, in this study we described an increase in antifungal activity when 
cyclodextrins and anabaenolysin are combined (III). Similarly, γ-cyclodextrin and 
amphotericin B showed an up to 60% increase in antifungal activity (Ruiz et al. 2014). 
Cyclodextrins have been used for diverse purposes and recent studies describe 
cyanobacterial hepatotoxins microcystins and nodularins to be able to strongly bind γ-
cyclodextrins, which could be used as a strategy to remove these toxins from the 
environment (Chen et al. 2011).  
Scytophycins are potent antifungal and cytotoxic compounds (Moore et al. 1989b, 
Carmeli et al. 1993). The 7-OMe-scytophycin-B derivative isolated from Anabaena sp. 
HAN21/1 presented an MIC/IC50 of 0.33/0.16 mg ml
-1
 (0.40/0.19 mM) for Candida 
albicans HAMBI 484 and 0.67/0.29 mg ml
-1
 (0.80/0.23 mM) for Candida guilliermondi 
HAMBI 257 (IV). Interestingly, a photocatalytic conversion of the 7-OMe-scytophycin-B 
might have affected antifungal activity (IV). Previous studies showed that Scytonema 
ocellatum increased the synthesis of tolytoxin (6-hydroxy-7-O-methyl-scytophycin B) in 
the presence of the fungal cell wall polyssacaride chitin (Patterson and Bolis 1997).  
Unidentified antifungal compounds were found in this study to be produced by 
Fischerella sp. CENA 298, Scytonema hofmanni PCC 7110 and Nostoc sp. N107.3 (IV). 
Preliminary results indicate that the antifungal compound of Nostoc sp. N107.3 does not 
have nitrogen and is purely polyketidic. Further analyses are needed to identify the 
chemical structure of these compounds.  
Some information is known concerning the cytotoxicity of the antifungal compounds 
analyzed in this study. Hassallidin B presented anticancer activity against human acute T 
cell leukemia (Jurkat ATCC-TIB-152; IC50 of 0.2 µg/ml) and murine aneuploid 
fibrosarcoma (L 929; at concentration of 1.0 µg/ml) (Neuhof et al. 2006c). Anabaenolysin 
lyses cells in a cholesterol-dependent manner and showed a higher haemolythic activity 
than the digitonin from plants (Oftedal et al. 2012). Scytophycins are potent cytotoxins 
against several human cancer cell lines, e.g. KB human epidermoid carcinoma (1 ng/ml) 
(Moore et al. 1989b, Yeung and Paterson 2002). Studies indicate that scytophycin affects 
the actin cytoskeleton at 100- to 1000-fold potency compared to the fungal compound 
cytochalasin (inhibits the polymerization of G-actin and depolymerization of F-actin) 
(Yeung and Paterson 2002). However, more studies concerning the bioavailability of these 
compounds, their action on biofilms and microbial selectivity are needed for further 
applications by the pharmaceutical industry. The fungal strains used in the present study 
were opportunistic fungi and additional tests performed with pathogenic fungal strains 
would provide further information of the antifungal activity of the new chemical variants 
studied here. Cyanobacteria are known to be a prolific source for bioactive compounds 
(Abed et al. 2008, Singh et al. 2011). Remarkably, we detected different strains from 
diverse environments producing known and yet to be discovered antifungal compounds. 
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5. Final remarks and future considerations 
 
 The analysis of 418 cyanobacteria isolates from diverse environments was 
accomplished in this study. Two new biosynthetic gene clusters were described (II and 
III). Analysis of the nonribosomal and nonribosomal/polyketide hybrid gene clusters aid 
in understanding the function of multimodular enzymatic systems producing hassallidin 
and anabaenolysin, respectively. The increased number of cyanobacterial genomes 
available in the database recently shows the huge information source for finding new 
biosynthetic gene clusters involved in the synthesis of natural products. However, 
interdisciplinary work in chemistry, biology and bioinformatics are necessary to uncover 
the unknown gene clusters. The connection between biosynthetic genes and their products 
is important for providing new information for further synthesis and biotechnological 
studies.  
 The evolutionary analysis improved our knowledge concerning the well-known 
microcystin biosynthetic gene cluster (I) and helped in the analysis of the newly 
discovered anabaenolysin gene cluster (III). The analysis, based on the evolution of genes 
involved in the synthesis of natural products, indicates highly variable genetic regions in 
these biosynthetic machineries. The heterologous expression of more diverse or more 
specific peptides could be obtained with modifications in these highly variable genetic 
regions. The results obtained in this doctoral study indicate that the replacement of the 
entire adenylation domain could result in the synthesis of more specific products (I). This 
allows the use of available resources for the synthesis of one or a few chemical variants 
and for facilitating target compound isolation. Although cyanobacteria only require a 
medium based on minerals and light for growth, they are slow-growing organisms. 
Heterologous expression of cyanobacterial compounds aids in obtaining a high yield and 
quicker synthesis of the target compounds. Understanding the evolutionary history of 
these genes might additionally help explain why cyanobacteria are still able to produce the 
respective natural products.  
 The chemical analysis included in this study improved our knowledge concerning 
different nonribosomal peptides and polyketides synthesized by the isolated 
cyanobacterial strains. The hepatotoxin microcystins are commonly detected in planktonic 
strains. A benthic and a lichen-associated cyanobacteria were found to produce 
microcystins (I), improving the information of cyanobacteria from different environments 
able to synthesize this well studied toxin. The new [Met
1
]microcystin was detected in 
planktonic Microcystis spp. cell extracts (I), increasing the number of microcystin variants 
known to the date.  
 Hassallidin, anabaenolysin synergistically acting together with cyclodextrins, 
scytophycin and unidentified compounds presented antifungal activities (II, III, IV). 
Anabaena sp. 90 was a natural mutant of hassallidin due to a deletion that occurred some 
time after cultivation in the culture collection. Contrastingly, although some of the 
cyanobacterial strains have been isolated and cultivated for almost 30 years, they are still 
able to produce antifungal hassallidin (II). Interestingly, over 40 variants of hassallidin 
were detected in the Anabaena sp. SYKE748A cell extract, additionally with information 
of other new genera detected as hassallidin producers such as Aphanizomenon, 
Cylindrospermopsis, Nostoc and Tolypothrix (II). Hassallidins have shown some level of 
cytotoxicity and the synthesis of this compound by bloom-forming strains, e.g. 
Cylindrospermopsis, indicates the importance to deeply study the possible role of 
hassallidins in human and animal poisoning cases and further to improve the monitoring 
of water used for drinking and recreation.  
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 Cyclodextrins were discovered over 100 years ago and are nowadays widely used by 
the pharmaceutical, food and chemical industries. Cyclodextrins have the ability to 
solubilize hydrophobic compounds and can be used to improve solubility and the delivery 
of drugs. The present study indicates that this method is also applied by cyanobacteria that 
showed an increase in antifungal activity by anabaenolysins combined with cyclodextrins 
(III). Due to an increase in antifungal resistence and the need for new antifungal drugs, a 
search for new bioactive compounds is currently needed. Three cyanobacterial strains 
were found to produce unidentified compounds that open the possility of finding new 
antifungal drugs (IV). Unfortunately, there are disadvantages in studying cyanobacteria for 
drug discovery such as the difficulties faced in genetic manipulation, solving the complex 
structures of the compounds produced and the slow growth of these organisms compared 
to some bacterial strains. However, with current advances in the study of chemical biology 
and biotechnology, there is a higher chance of success in the synthesis of cyanobacterial 
compounds for a broad range of uses. The fact that cyanobacteria have lived on Earth for 
3500 million years in a daily combat against parasitic fungi or in competition with fungi in 
the natural environments, make them a great source for antifungal drug discovery. To 
overcome the problems faced by cyanobacterial drug research, more studies are necessary 
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Supplementary Table S1. Strains used in the present doctoral thesis are indicated in gray or black 
depending on which study they have been included from. Strains detected producing the studied 
cyanobacterial compound(s) are highlighted in black. 

























































Anabaena         
Anabaena sp. 0TU33S16 Lake Tuusulanjärvi, Finland 2000   II   
Anabaena sp. 0TU43S7 Lake Tuusulanjärvi, Finland 2000   II   
Anabaena sp. 0TU43S8 Lake Tuusulanjärvi, Finland 2000   II   
Anabaena sp. 1TU23S3 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU26S10 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU28S8 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU28S13 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU32S11 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU33S8 Lake Tuusulanjärvi, Finland 2001 AJ6630432  II   
Anabaena sp. 1TU33S10 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU35S12 Lake Tuusulanjärvi, Finland  2001 AJ630423  II III  
Anabaena sp. 1TU36S8 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU36S9 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU39S17 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU44S9 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 1TU44S16 Lake Tuusulanjärvi, Finland 2001   II   
Anabaena sp. 14 Lake Sääskjärvi, Finland 1985   II   
Anabaena sp. 37 Lake Sääskjörvi, Finland 1985    III IV 
Anabaena sp. 54 Lake Sääskjärvi, Finland 1986   II   
Anabaena sp. 66 Lake Kiikkara, Finland 1986   II   
Anabaena sp. 66B Lake Kiikkara, Finland 1986   II   
Anabaena sp. 79 Lake Sääskjärvi, Finland 1986   II   
Anabaena sp. 82 Lake Karpjärvi, Finland 1986   II   
Anabaena sp. 86 Lake Villikalanjärvi, Finland 1986   II   
Anabaena sp. 90 Lake Vesijärvi, Finland 1986 AJ133156 I II   
Anabaena sp. 90 M3 (apdA-
mutant) 
Knock out strain of  Anabaena sp. 
90 (Rouhiainen et al. 2000) 
1999   II   
Anabaena sp. 130 Lake Säyhteenjärvi, Finland 1986   II   
Anabaena sp. 141 Lake Vesijärvi, Finland 1986   II   
Anabaena sp. 191A2 Lake Rautjärvi, Finland 1986   II   
Anabaena sp. 202A1 Lake Vesijärvi, Finland 1987   II   
Anabaena sp. 202A1/35 Lake Vesijärvi, Finland 1987   II   
Anabaena sp. 202A2 Lake Vesijärvi, Finland 1987   II   
Anabaena sp. 258 Lake Tuusulanjärvi, Finland 1990   II   
Anabaena sp. 288 Lake Littoistenjärvi, Finland  1990   II   
Anabaena sp. 293 Lake Tuusulanjärvi, Finland 1992   II   
Anabaena sp. 299A Lake Vesijärvi, Finland 1992   II   
Anabaena sp. 299B Lake Vesijärvi, Finland 1992   II   
Anabaena sp. 301 The Baltic Sea, Gulf of Finland 1992   II   
Anabaena sp. 318 Helsinki coast, “39A”, BS 
planktonic 
1998    III  
Anabaena sp. 326 Lake Lohjanjärvi, Finland 1998   II   
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Anabaena sp. 335/1 River Juupajoki, Finland 1999   II   
Anabaena sp. AnapI-Bos00 Unknown unknown   II   
Anabaena sp. Anapl-Nech00 Nechranice reservoir, North-West 
Bohemia, Czech Republic 
2000   II   
Anabaena sp. ANASP-URB Urbensky pond, Czech Republic unknown   II   
Anabaena sp. Anaspi-Vrb00 Vrbenský pond, South-Bohemia, 
Czech Republic 
2000   II   
Anabaena variabilis ATCC 29413 Mississippi, USA Freshwater 1964 NR_074300    IV 
Anabaena sp. BECID19 The Baltic Sea, Pikku-Kallahti, 
Finland  
2001 EF583857  II III  
Anabaena sp. BECID 20 The Baltic Sea, Pikku-Kallahti, 
Finland, epiphytic 




Helsinki, Vuosaari, Gulf of 
Finland, epiphytic 2001 
AJ630426   III  
Anabaena sp. BECID 23 The Baltic Sea, Kallahti, Finland, 
epiphytic 
2001   II III  
Anabaena sp. BECID 30 
Baltic Sea, Helsinki, Finland; 
epilithic 2001 
   III  
Anabaena sp. BECID 32  The Baltic Sea, Gulf of  Finland, 
Pikku-Kallahti, Finland 
2001    III  
Anabaena sp. BECID38 The Baltic Sea, Pikku-Kallahti, 
Finland  
2001   II   
Anabaena sp. 
BIR 3 
Baltic Sea, Gulf of Finland 
planktonic 2003 
   III  
Anabaena sp. 
BIR 25 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR 32      III  
Anabaena sp. BIR 42      III  
Anabaena sp. 
BIR 49 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 52 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR 54 The Baltic Sea, Gulf of Finland 2004   II   
Anabaena sp. BIR 78 The Baltic Sea, Gulf of Finland, 
planktonic 
2004   II III  
Anabaena sp. 
BIR 84 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 94 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 162 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 208 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR 219 The Baltic Sea, Gulf of Finland 2004   II   
Anabaena sp. 
BIR 241 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 246 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 247 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR 256 The Baltic Sea, Gulf of Finland, 
planktonic 
2004   II III  
Anabaena sp. BIR 257 The Baltic Sea, Gulf of Finland 2004   II   
Anabaena sp. 
BIR 258 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR 259 The Baltic Sea, Gulf of Finland 2004   II   
Anabaena sp. 
BIR 260 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 348 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. 
BIR 441 
Baltic Sea, Gulf of Finland 
planktonic 2004 
   III  
Anabaena sp. BIR JV1 The Gulf of Finland      IV 
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Anabaena sp. CENA 247 
Rio Camarão/CE river water, 
Brazil 
2009     IV 
Anabaena sp. HAN 7/1 
Kobben, Hanko, Finland small 
stones in the water 
2012     IV 
Anabaena sp. HAN 15/2 
Kobben, Hanko, Finland 
Gastropod from waterline 
2012 +    IV 
Anabaena sp. HAN 21/1 
Kobben, Hanko, Finland 
Gastropod 10 cm under water 
2012 +    IV 
Anabaena sp. HAN 37/1 
Hanko Casino sea shore, Hanko, 
Finland green biofilm 
2012 +    IV 




    IV 
Anabaena sp. NIES-73 Lake Kasumigaura, Japan 1978   II   
Anabaena sp. NIVA 269/2 Lake Frøylandsvatnet, Norway  1990   II   
Anabaena sp. NIVA 269/6 Lake Frøylandsvatnet, Norway  1990   II   
Anabaena sp. NIVA 270/1 Lake Arefjordsvatnet, Norway 1990   II   
Anabaena sp. NIVA-CYA 
83/1 
Lake Edlandsvatnet, Norway 1981   II   
Anabaena sp. NIVA-CYA 
267/4 
Lake Fammestadtjønni, Norway 1990   II   
Anabaena sp. PH 57 Lake Veljesø, Denmark 1993   II   
Anabaena sp. PH 71  Lake Furesø, Denmark 1993   II   
Anabaena sp. PH 118 Lake Langesø, Denmark 1993   II   
Anabaena sp. PH 133  Lake Arresø, Denmark 1993 AJ293110  II  IV 
Anabaena sp. PH 189  Lake Tuel, Denmark 1993   II   
Anabaena sp. PH 256  Lake Knud, Denmark 1994   II   
Anabaena sp. PH 262  Lake Knud, Denmark 1994   II   
Anabaena sp. PMC 9701 Champsanglard dam, France 1997   II   
Anabaena sp. PMC 9702 Champsanglard dam, France 1998   II   
Anabaena sp. PCC 7108 
Moss Beach, California USA 
interdidal zone 
1970 AJ133162    IV 
Anabaena sp. PCC 7122  Pond, England 1939 AF091150  II  IV 
Anabaena sp. PCC 9208 Soil, Galicia, Spain unknown   II   
Anabaena sp. Schmidke 
JAHNKE/4 
Rostock, Germany unknown   II   
Anabaena sp. SYKE 658 Lake Enäjärvi, Finland planktonic 1999   II III  
Anabaena sp. SYKE 701 Lake Enäjärvi, Finland unknown   II   
Anabaena sp. SYKE 741 Maarian allas, Finland 1999   II III  
Anabaena sp. SYKE 748A Lake Tuusulanjärvi, Finland 1999 KF631396  II III  
Anabaena sp. SYKE 763A Lake Tuusulanjärvi, Finland 1999   II   
Anabaena sp. SYKE 790 Halikko, Finland unknown   II   
Anabaena sp. SYKE 816 The Baltic Sea, Gulf of Finland 1999   II   
Anabaena sp. SYKE844/16 Kisakallio, Finland unknown   II   
Anabaena sp. SYKE 844A Kisakallio, Finland 1999    III  
Anabaena sp. SYKE 844B Lake Lohjanjärvi, Finland 1999   II   
Anabaena sp. SYKE 844C Kisakallio, Finland 1999   II   
Anabaena sp. SYKE 966 Lake Littoistenjärvi, Finland unknown   II   
Anabaena sp. SYKE 971/6 Lake Kotojärvi, Finland 1999 +  II   
Anabaena sp. SYKE 971/9 Lake Kotojärvi, Finland 1999   II   
Anabaena sp. SYKE 1228 Joutikas, Finland 1999   II   












    IV 
Anabaena sp. XPORK 1C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XPORK 1D The Baltic Sea coast, Porkkala 1999   II III  
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cape,  Finland 
Anabaena sp. XPORK 4C The Baltic Sea coast, Porkkala 
cape,  Finland, epiphytic 
1999    III  
Anabaena sp. XPORK 4D The Baltic Sea coast, Porkkala 
cape,  Finland, epiphytic 
1999    III  
Anabaena sp. XPORK 5C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. 
XPORK 6A 
Baltic Sea, Cape Porkkala benthic 
sediment 1999 
   III  
Anabaena sp. XPORK 6B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II  IV 
Anabaena sp. XPORK 6C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XPORK 13A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XPORK 15D The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XPORK 15F Baltic Sea, Cape Porkkala benthic 1999    III  
Anabaena sp. XPORK 34A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
Anabaena sp. 
XPORK 36C 
Baltic Sea, Cape Porkkala 
periphytic 1999 
   III  
Anabaena sp. XPORK 36D The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XSPORK 2A 
Baltic Sea, Cape Porkkala benthic, 
gastropod 1999 
   III  
Anabaena sp. XSPORK 7B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999 KF631399  II III  
Anabaena sp. XSPORK 14D The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XSPORK 27C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Anabaena sp. XSPORK 36B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
         
Aphanizomenon         
Aphanizomenon 
issatschenkoi 
0tu37s7 Lake Tuusulanjärvi, Finland 2000   II III  
Aphanizomenon sp. 1TU26S2 Lake Tuusulanjärvi, Finland 2001   II III  
Aphanizomenon sp. 1TU29S13 Lake Tuusulanjärvi, Finland 2001   II III  
Aphanizomenon 
flos-aquae 
1tu37s13 Lake Tuusulanjärvi, Finland 2001   II   
Aphanizomenon sp. 3 Lake Långsjön, Åland Island  1985   II III  
Aphanizomenon sp. 37 Lake Sääskjärvi, Finland 1985   II   
Aphanizomenon sp. 201 Lake Bodomjärvi, Finland  1987   II III  
Aphanizomenon sp. 313 Lake Tuusulanjärvi, Finland 1997 
 
  II III  
Aphanizomenon sp. 326 Lake Lohjanjärvi, Finland 1998   II III  




1986 140 1/1 
Freshwater, Lough Neagh, Ireland 1986 AJ630444  II   
Aphanizomenon sp. SYKE 761/II Raisio-Naantali, Finland unknown   II III  
         
Aphanocapsa         
Aphanocapsa sp. CENA 223 
Morro Branco/CE water 
accumulated, Brazil 
2009     IV 
         
Aphanothece         




    IV 
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Calothrix         
Calothrix sp. 441/2 Lake Säyhteenjärvi,Finland     III  
Calothrix sp. 
BECID 1 
Hel., Matosaari, BS, Fin. 
periphytic 2001 
   III  
Calothrix sp. 
BECID 4 
Baltic Sea, Gulf of Finland 
Brackish water 2001 
   III  
Calothrix sp. 
BECID 9 
Baltic Sea, Gulf of Finland, 
epilithic 2001 
   III  
Calothrix sp. BECID 16 The Baltic Sea, Helsinki, Finland; 
epilithic 
2001   II   
Calothrix sp. BECID 18 The Baltic Sea, Helsinki, Finland; 
sediment benthic 
2001   II III  
Calothrix sp. BECID 26 Baltic Sea, Vuosaari, epilithic 2001    III  
Calothrix sp. 
BECID 33 
Helsinki, Vuosaari, Gulf of 
Finland, epilithic 2001 
   III  
Calothrix sp. CAL336/1 Lake Enäjärvi, Finland 1999   II III  
Calothrix sp. Cal 336/2 Vihti, Enäjärvi Laukilanlahti      IV 
Calothrix sp. Cal 336/3 Lake Enäjärvi, Finland Lake water 1999   II III IV 
Calothrix sp. CENA 283 Piauí soil, Brazil 2009     IV 
Calothrix sp. HAN 6/3 
Kobben, Hanko, Finland Growth 
on rock waterline 
2012 +    IV 
Calothrix sp. HAN 6/4 
Kobben, Hanko, Finland Growth 
on rock waterline 
2012 +    IV 
Calothrix sp. HAN 8/2 
Kobben, Hanko, Finland Growth 
on rock waterline 
2012 +    IV 
Calothrix sp. HAN 12/2 
Kobben, Hanko, Finland black 
spots film, benthic 
2012 +    IV 
Calothrix sp. HAN 16/2 
Kobben, Hanko, Finland 
Waterplant from shallow water 
2012 +    IV 
Calothrix sp. HAN 17/1 
Kobben, Hanko, Finland Red 
biofilm 
2012 +    IV 
Calothrix sp. HAN 19/2 
Kobben, Hanko, Finland 
black/green biofilm from waterline 
2012 +    IV 
Calothrix sp. HAN 20/3 
Kobben, Hanko, Finland sediments 
10 cm under water 
2012 +    IV 
Calothrix sp. HAN 21/3 
Kobben, Hanko, Finland 
Gastropod 10 cm under water 
2012 +    IV 
Calothrix sp. HAN 21/4 
Kobben, Hanko, Finland 
Gastropod 10 cm under water 
2012 +    IV 
Calothrix sp. HAN 21/5 
Kobben, Hanko, Finland 
Gastropod 10 cm under water 
2012 +    IV 
Calothrix sp. HAN 22/1 
Kobben, Hanko, Finland Black 
biofilm 
2012 +    IV 
Calothrix sp. HAN 30/2 
Hanko Casino sea shore, Hanko, 
Finland Green biofilm and 
Gastropod 
2012 +    IV 
Calothrix sp. HAN 30/3 
Hanko Casino sea shore, Hanko, 
Finland Green biofilm and 
Gastropod 
2012 +    IV 
Calothrix sp. HAN 33/1 
Hanko Casino sea shore, Hanko, 
Finland brown biofilm on the rock 
2012 +    IV 
Calothrix sp. HAN 33/2 
Hanko Casino sea shore, Hanko, 
Finland Brown/yellow biofilm 
2012 +    IV 
Calothrix sp. HAN 36/2 
Hanko Casino sea shore, Hanko, 
Finland Biofilm 
2012 +    IV 
Calothrix sp. HAN 37/2 
Hanko Casino sea shore, Hanko, 
Finland green biofilm 
2012 +    IV 
Calothrix sp. HAN 37/3 
Hanko Casino sea shore, Hanko, 
Finland Green biofilm 
2012 +    IV 
Calothrix sp. HAN 38/2 
Hanko Casino sea shore, Hanko, 
Finland Red biofilm 
2012 +    IV 
Calothrix sp. PCC 7102 Antofagasta, Chile sand 1958     IV 
Calothrix sp. PCC 7103 
Unknown herbarium specimen of 
Anacystis Montana 
 AM230700    IV 
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Calothrix sp. PCC 7507 Sphagnum bog ,Vierwaldstättersee 1972 NR_102891  II III IV 
Calothrix sp. PCC 7714 Pool, Aldabra Atoll, India 1972   II III  
Calothrix sp. PCC 7715 Thermal spring, Dax, France 1964   II III  
Calothrix sp. UHCC 0022       IV 
Calothrix sp. XP 10A The Baltic Sea coast, Porkkala 
cape,  Finland, epilithic 
1999   II III  
Calothrix sp. XP 11C The Baltic Sea coast, Porkkala 
cape,  Finland benthic sediment 
1999   II III  
Calothrix sp. XPORK 2B The Baltic Sea coast, Porkkala 
cape,  Finland benthic, periphytic 
1999   II   
Calothrix sp. XPORK 4B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
Calothrix sp. XSPORK  3 The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Calothrix sp. XSPORK 4A The Baltic Sea coast, Porkkala 
cape,  Finland epiphytic 
1999   II III  
Calothrix sp. XSPORK 10A 
Baltic Sea, Cape Porkkala, 
epilithic 1999 
   III  
Calothrix sp. XSPORK 36C The Baltic Sea coast, Porkkala 
cape,  Finland periphytic 
1999   II III  
         
Cyanobium         
Cyanobium sp. HIID A3A Hiidenvesi, Kirkkojärvi sediment 1999     IV 
         
Cyanospira         
Cyanospira sp. CENA 215 
Morro Branco/CE water 
accumulated 2009 
    IV 
         
Cylindrospermopsis         
Cylindrospermopsis 
raciborskii  
ATC-9502  Lake Balaton, Hungary 1994   II   
Cylindrospermopsis 
raciborskii  
CS505/8 Freshwater, Solomon Dam, North 
Queensland, Australia 
1996 EU552055  II  IV 
         
Cylindrospermum         
Cylindrospermum 
sp. 
PCC 7417  Greenhouse soil, Stockholm, 
Sweden 







    IV 
         
Fischerella         
Fischerella sp. CENA161 Dam Brazil 2004 EU840724 I    
Fischerella sp. PCC 7414 Hot spring, New Zealand unknown   II III  
Fischerella sp. PCC 9339 Unknown unknown AB075984    IV 
Fischerella 
muscicola  
SAG 1427-1 Freswater, Rice field,  India  1951   II III  
         
Geitlerinema         
Geitlerinema sp. 
CENA 224 
Morro Branco/CE water 
accumulated, Brazil 
2009     IV 
Geitlerinema sp. 
CENA 228 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Geitlerinema sp. 
CENA 252 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
         
Gloeotrichia         
Gloeotrichia sp. 
CENA 250 
Rio Camarão/CE river water, 
Brazil 
2009     IV 
Gloeotrichia sp. 
CENA 272 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
 71 
 
Gloeotrichia sp. CENA 285 Piauí soil, Brazil 2009     IV 
Gloeotrichia sp. CENA 288 Ceará soil, Brazil 2009     IV 
         
Hapalosiphon         
Hapalosiphon 
hibernicus 
BZ-3-1 Soil or freshwater mud sample, 
Oahu, Hawaii 
unknown EU151900  II III  
         
Leptolyngbya         
Leptolyngbya sp. 
CENA 229 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Leptolyngbya sp. 
CENA 254 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Leptolyngbya sp. 
CENA 256 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Leptolyngbya sp. CENA 282 Piauí soil, Brazil 2009     IV 
Leptolyngbya sp. CENA 292 Ceará soil, Brazil 2009     IV 
Leptolyngbya sp. CENA 299 Rio Grande do Norte soil, Brazil 2009     IV 
Leptolyngbya sp. HIID A16A 
Hiidenvesi, Kirkkojärvi sediment, 
Finland 
1999 
    IV 
Leptolyngbya sp. HIID A19B 
Hiidenvesi, Kirkkojärvi sediment, 
Finland 
1999 
    IV 
Leptolyngbya sp. HIID A25A 
Hiidenvesi, Kirkkojärvi sediment, 
Finland 
1999 
  II  IV 




    IV 




    IV 
         
Limnothrix         
Limnothrix sp. 
CENA 217 
Morro Branco/CE water 
accumulated, Brazil 
2009     IV 
         
Merismopedia         
Merismopedia sp. CENA 264 Icó/CE water accumulated, Brazil 2009     IV 
         
Microchaete         
Microchaete sp. 
CENA 251 
Rio Camarão/CE river water, 
Brazil 
2009     IV 
         
Microcystis         
Microcystis 
aeruginosa 
NPLJ-4 Brazil unknown JQ771624 I    
Microcystis sp. RST 9501 Brazil 1995 JQ771625 I    
         
Myxosarcina         
Myxosarcina sp. 
CENA 240 
Cisterna/Canindé/CE water in the 
cistern, Brazil 
2009     IV 
Myxosarcina sp. 
CENA 241 
Cisterna/Canindé/CE water in the 
cistern, Brazil 
2009     IV 
Myxosarcina sp. 
CENA 242 
Cisterna/Canindé/CE water in the 
cistern, Brazil 
2009     IV 
Myxosarcina sp. 
CENA 244 
Cisterna/Canindé/CE water in the 
cistern, Brazil 
2009     IV 
         
Nodularia         
Nodularia 
harveyana 
BECID 27 The Baltic Sea, epiphytic 2001   II III  
Nodularia 
harveyana 
BECID 29 The Baltic Sea, epilithic 2001   II III  





Bo53 The Baltic Sea Shallow coastal 
water 
1992   II III  
Nodularia 
spumigena 
BY1 The Baltic Sea planktonic 1986 AF268004  II III  
Nodularia sp. HEM 
Brackish water, Baltic Sea 
planktonic 1986 
AF268005   III  
Nodularia 
harveyana 
Hübel 1983/300 The Baltic Sea  1983   II   
Nodularia 
sphaerocarpa 
PCC 7804 France benthic 1966   II III  
Nodularia 
sphaerocarpa 
PCC 73104/1 Canada soil 1972   II   
         
Nostoc         
Nostoc sp. 1tu14s8 Lake Tuusulanjärvi, Finland 2001   II   
Nostoc fc. calcicola VI Field, Dobre' Pole, Czech Republic 
field 
1998   II III  
Nostoc 
ellipsosporum 
V Field, Nezamyslice, Czech 
Republic field 
1990   II III  
Nostoc calcicola 6 sf Calc Dobre Pole 1998 +    IV 
Nostoc sp. 102I       IV 
Nostoc sp. N107.3 Lichen associated  +    IV 
Nostoc sp. 113.5 Lichen associated unknown KF631395  II   
Nostoc sp. 116.6.23       IV 
Nostoc sp. 116.7.5       IV 
Nostoc sp. 152 Lake Sääksjärvi, Finland  AJ133161    IV 
Nostoc sp. 159 Lake Haukkajärvi, Finland 1986 KF631398  II  IV 
Nostoc sp. 342/7 Kemiö, Pederså     III  
Nostoc sp. ATCC 53789 Arron Island, Scotland; lichen-
associsted 
unknown   II III  
Nostoc sp. BECID 2 The Baltic Sea, Gulf of Finland 2001   II III  
Nostoc sp. BECID 32 
(JL28102001/5) 
The Baltic Sea, Gulf of  Finland, 
Pikku-Kallahti, Finland, epilithic 
2001   II   
Nostoc sp. BIR L1S7 The Gulf of Finland      IV 
Nostoc sp. CENA 219 
Morro Branco/CE water 
accumulated 2009 
+    IV 
Nostoc sp. CENA 221 
Morro Branco/CE water 
accumulated, Brazil 
2009     IV 
Nostoc sp. CENA 227 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Nostoc sp. CENA 234 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Nostoc sp. CENA 237 
Lagoa Povoado Nova Aurora/CE 
water pond used by cattle, Brazil 
2009     IV 
Nostoc sp. CENA 238 
Lagoa Povoado Nova Aurora/CE 
water pond used by cattle, Brazil 
2009     IV 
Nostoc sp. CENA 239 
Lagoa Povoado Nova Aurora/CE 
water pond used by cattle, Brazil 
2009     IV 
Nostoc sp. CENA 257 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 258 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 259 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 261 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 269 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 271 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
Nostoc sp. CENA 274 Bahia soil, Brazil 2009     IV 
Nostoc sp. CENA 275 Bahia soil, Brazil 2009     IV 
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Nostoc sp. CENA 277 Bahia soil, Brazil 2009     IV 
Nostoc sp. CENA 278 Bahia soil, Brazil 2009     IV 
Nostoc sp. CENA 293 Ceará soil, Brazil 2009     IV 
Nostoc sp. CENA 296 Ceará soil, Brazil 2009     IV 
Nostoc sp. CENA 298 Paraíba soil, Brazil 2009 +    IV 
Nostoc sp. HAN 10/1 
Kobben, Hanko, Finland small 
pond on a rock 
2012 +    IV 
Nostoc sp. HAN 11/1 
Kobben, Hanko, Finland small 
pond on a rock 
2012 +    IV 
Nostoc sp. HAN 22 
Kobben, Hanko, Finland biofilm 
growth on rock waterline 
2012 +    IV 
Nostoc sp. HAN 24/1 Kobben, Hanko, Finland epilithic 2012 +    IV 
Nostoc sp. HAN 27 
Hanko Casino sea shore, Hanko, 
Finland small rock pond 
2012 +    IV 




    IV 
Nostoc sp. IO-102-I Rock in Sysmä, Finland; lichen-
associated  
2000 AY566855  II III  
Nostoc sp. N115.3.2 Lichen, unknown      IV 
Nostoc sp. N122.4.B Lichen, unknown      IV 
Nostoc sp. N123.4 Lichen, unknown      IV 
Nostoc sp. N124.3.B Lichen, unknown      IV 
Nostoc sp. N135.9.1 Lichen, unknown      IV 
Nostoc sp. N990622Ш Lichen, unknown      IV 
Nostoc sp. N990653.17 Lichen, unknown      IV 
Nostoc sp. N138  Lichen, unknown      IV 
Nostoc sp. PCC 7120 Unknown unknown NR_074310    IV 
Nostoc punctiforme PCC 73102 
Australia root section, Macrozamia 
sp. 
1973 AF027655    IV 
Nostoc sp. UK1 
Oulunkylä, Helsinki, Finland 
lichen Peltigera sp. 
 
    IV 
Nostoc sp. UK2aImI 
Oulunkylä, Helsinki, Finland 
Lichen Peltigera praetextata 
 +    IV 
IV 
Nostoc sp. UK 3 Itä-Pakila, Helsinki, Finland lichen 2006   II III  
Nostoc sp. UK4 
Itä-Pakila, Helsinki, Finland lichen 
Peltigera spuria 
 
    IV 
Nostoc sp. UK7BIIm 
Itä-Pakila, Helsinki, Finland 
Lichen Peltigera canina? 
     IV 
Nostoc sp. UK18AI 
Autti, Finland Lichen Peltigera 
leucophlebia 
2006 +    IV 
Nostoc sp. UK18AШ 
Autti, Finland lichen Peltigera 
leucophlebia 
 
    IV 
Nostoc sp. UK18AIV 
Autti, Finland Lichen Peltigera 
leucophlebia 
     IV 
Nostoc sp. UK18BI 
Autti, Finland Lichen Peltigera 
leucophlebia 
     IV 
Nostoc sp. UK18BП 
Autti, Finland Lichen Peltigera 
leucophlebia 
     IV 
Nostoc sp. UK18BШ 
Autti, Finland Lichen Peltigera 
leucophlebia 
     IV 
Nostoc sp. UK18BIV 
Autti, Finland Lichen Peltigera 
leucophlebia 
     IV 
Nostoc sp. UK18bV Autti; lichen-associated, unknown   II III  
Nostoc sp. UK35 lichen-associated, Finland      IV 
Nostoc sp. UK89IIa Finland unknown JQ771626 I II   
Nostoc sp. XHIID A1 
Hiidenvesi, Kirkkojärvi sediment, 
Finland 
1999 
    IV 




   III IV 




    IV 
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    IV 




    IV 




    IV 




    IV 




    IV 
Nostoc sp. XHIID C12 Hiidenvesi, Nummelanselkä, 
Finland 
1999   II III  




    IV 




    IV 




    IV 




    IV 




    IV 
Nostoc sp. XPORK 4A The Baltic Sea coast, Porkkala 
cape,  Finland benthic 
1999   II III  
Nostoc sp. XPORK 5A The Baltic Sea coast, Porkkala 
cape,  Finland epithytic 
1999 +  II III IV 
Nostoc sp. XPORK 14A The Baltic Sea coast, Porkkala 
cape,  Finland benthic 
1999   II III  
Nostoc sp. XPORK 15C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Nostoc sp. XPORK 24A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
Nostoc sp. XPORK 24B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II III  
         
Phormidium         
Phormidium sp. CENA 270 Brazil 2009 JQ771627 I   IV 
Phormidium sp. DVL1003c USA unknown JQ771628 I    
Phormidium sp.  HIID B22B Hiidenvesi, Mustionselkä sediment 1999     IV 
         
Planktothrix         
Planktothrix sp. 126/8 Lake Vesijärvi, Finland 1984 AJ133166   III  
Planktothrix sp. CENA 236 
Povoado Novo Aurora/CE water in 
the pond, Brazil 
2009     IV 
Planktothrix sp. 
CYA 18 
Lake Gjersjøen, Norway 
planktonic 1971 
   III  
         
Pseudanabaena         
Pseudanabaena sp. 
CENA 235 
Povoado Novo Aurora/CE water in 
the pond, Brazil 
2009     IV 
Pseudanabaena sp. 
CENA 266 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
Pseudanabaena sp. 
CENA 267 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
Pseudanabaena sp. CENA 287 Piauí soil, Brazil 2009     IV 
Pseudanabaena sp.  HIID A13A 
Hiidenvesi, Kirkkojärvi sediment, 
Finland 
1999 
    IV 




    IV 




    IV 
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Rivularia         
Rivularia sp. BECID 10 Baltic Sea, Kirkkonummi, Finland; 
sediment benthic, epilithic 
1999   II III  
Rivularia sp. BECID 14 
Helsinki Hettoniemi, Gulf of 
Finland, epilithic 2001 
   III  
Rivularia sp. PCC 7116 Sea water, Baja California, USA 1968   II   
Rivularia sp. XPORK 3A The Baltic Sea coast, Porkkala 
cape,  Finland periphytic, benthic 
1999   II III  
Rivularia sp. XPORK 16B The Batic Sea coast, Porkkala 
cape, Finland, epilithic 
1999   II III  
         
Synechococcus         
Synechococcus sp. 
CENA 222 
Morro Branco/CE water 
accumulated, Brazil 
2009     IV 
Synechococcus sp. 
CENA 232 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Synechococcus sp. 
CENA 233 
Açude São Mateus/CE water used 
by population (lake), Brazil 
2009     IV 
Synechococcus sp. 
CENA 249 
Rio Camarão/CE river water, 
Brazil 
2009     IV 
Synechococcus sp. 
CENA 253 
Sodrelândia/BA water in the pond, 
Brazil 
2009     IV 
         
Synechocystis         




    IV 
         
         
Scytonema         
Scytonema sp. CENA 268 
Paulista/PA water in the pond, 
Brazil 
2009     IV 
Scytonema sp. HAN 3/2 
Kobben, Hanko, Finland green 
biofilm in the pond 
2012     IV 
Scytonema sp.  PCC 7110 Limestone cave, Crystal Cave, 
Bermuda limestone 
1971   II III IV 
         
Snowella         
Snowella sp. 0tU37S4 Lake Tuusulanjärvi, Finland 2000    III  
         
Stigonema         
Stigonema sp. CENA 291 Ceará soil, Brazil 2009     IV 
Stigonema sp. CENA 295 Ceará soil, Brazil 2009     IV 
         
Tolypothrix         
Tolypothrix sp. BIR MGR4 The Gulf of Finland      IV 
Tolypothrix sp. HAN 25/1 Kobben, Hanko, Finland epilithic 2012 +    IV 
Tolypothrix sp. HAN 26/2 
Hanko Casino sea shore, Hanko, 
Finland Black biofilm, Hanko 
Casino sea shore, Hanko, Finland 
2012 +    IV 
Tolypothrix sp.  PCC 7101 Soil, Borneo 1950 
unknown 
  II  IV 
Tolypothrix sp.  PCC 7415 Greenhouse soil, Stockholm, 
Sweden 
1972   II  IV 
Tolypothrix sp.  PCC 7504 Aquarium, Stockholm, Sweden 1972   II  IV 




 II   
Tolypothrix sp.  TOL328 University of Kuopio, Green 
house, Finland soil 
1999   II III IV 
Tolypothrix sp. XPORK 34B Porkkala cape      IV 
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Trichormus         
Trichormus 
doliolum 
1 Unknown unknown   II III  
Trichormus azollae BAI/1983 Unknown 1983   II III  
Trichormus 
variabilis 
GREIFSWALD Unknown 1992   II III  
Trichormus sp. HIID B6.A Freshwater, Hiidenvesi, 
Mustionselkä, Finland 
 
1999   II III IV 




    IV 
         
Non classified 
cyanobacteria 
        
Chroococcales CENA 263 
Baixão dos Bois/BA water 
accumulated, Brazil 
2009     IV 
Chroococcales CENA 276 Bahia soil, Brazil 2009     IV 
 CENA 281 Piauí soil, Brazil 2009     IV 
Nostocales CENA 294 Ceará soil, Brazil 2009     IV 
 HAN 3/1 
Kobben, Hanko, Finland green 
biofilm in the pond 
2012     IV 
 HAN 6/1 
Kobben, Hanko, Finland Growth 
on rock waterline 
2012     IV 
 HAN 15/3 
Kobben, Hanko, Finland 
Gastropod from waterline 
2012     IV 
 HAN 19/3 
Kobben, Hanko, Finland 
black/green biofilm from waterline 
2012     IV 
 HAN 20/1 
Kobben, Hanko, Finland sediments 
10 cm under water 
2012     IV 
 HAN 21/2 
Kobben, Hanko, Finland 
Gastropod 10 cm under water 
2012     IV 
 HAN22/2 
Kobben, Hanko, Finland Black 
biofilm 
2012     IV 
 HAN 29/3 
Hanko Casino sea shore, Hanko, 
Finland green biofilm on the rock 
2012     IV 
 HAN 31/a Hanko, Finland biofilm 2012     IV 
 HAN 32/2 
Hanko Casino sea shore, Hanko, 
Finland epilithic 
2012     IV 
 HAN 40/1 
Hanko Casino sea shore, Hanko, 
Finland epilithic 
2012     IV 
  HIID A5.A Hiidenvesi, Kirkkojärvi, Finland 1999   II   
  HIID A7 Hiidenvesi, Kirkkojärvi, Finland 1999   II   
  HIID A18.A Hiidenvesi, Kirkkojärvi, Finland 1999   II   
  HIID B4.B Hiidenvesi, Mustionselkä, Finland 1999   II   
  HIID B11.B Hiidenvesi, Mustionselkä, Finland 1999   II   
  HIID B16.A Hiidenvesi, Mustionselkä, Finland 1999   II   
  HIID B22.A Hiidenvesi, Mustionselkä, Finland 1999   II   
  PORK 10 The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  UHCC 0006 Pernajanlahti, Finland 2009   II   
  UHCC 0007 Pernajanlahti, Finland 2009   II   
  UHCC 0020 Bonäsbåset, Finland 2009   II   
  UHCC 0021 Lake Puujärvi, Finland 2009   II   
  XHIID A6 Hiidenvesi, Kirkkojärvi, Finland 1999   II   
  XHIID C1 Hiidenvesi, Nummelanselkä, 
Finland 
1999   II   
  XHIID D4 Hiidenvesi, Kiihtelyksenselkä, 
Finland 
1999   II   
  XHIID D8 Hiidenvesi, Kiihtelyksenselkä, 
Finland 
1999   II   




  XPORK 2C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XPORK 14F The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK 15B The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK 15C The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK 20A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK  22A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK  24A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
  XSPORK  34A The Baltic Sea coast, Porkkala 
cape,  Finland 
1999   II   
+ 16S rRNA sequences are not available in the NCBI. 
 
